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Abstract 
The Use of Methoprene In the Preparation of 
r 
an Immunogen from Non-ImmunogenIc Insect Growth 
Regulators with Juvenile Hormone Activity: 
Development of a Model System 
May, 1988 
Joanne V. Mel, B.S., University of Massachusetts 
M.S., University of Massachusetts 
Directed by: Professor Chih-Ming Yin 
The Insect growth regulator , methoprene, is a 
small, non-ImmunogenIc molecule which must be conjugated 
to a large carrier molecule to generate an Immunological 
response In mammals. An Immunogen has been developed 
which retains the features of the methoprene molecule, 
namely a methoxy and an ester function. The Immunogen 
consists of methoprene acid linked as an ester to a 
spacer group, which is in turn conjugated to a carrier 
protein. The spacer group, 4-hydroxybutanoIc acid, was 
protected to prevent its cyclyzation prior to coupling 
to methoprene acid. The protecting groups used were 
removed with specific reagents under mild conditions. 
Two methods of conjugating methoprene to a protein 
via activated esters were studied. The first method used 
an N-hydroxysuccinimde ester derivative and conjugated 53 
molecules of methoprene per molecule of protein. A 
second method used a water soluble, 1-hydroxy-2-nitro-4- 
vi 
benzenesuIfonate ester derivative of methoprene and 
conjugated 30 molecules of the methoprene per molecule of 
proteIn. 
The immunogen was used to Immunize eight BALB/c 
mice. The indirect enzyme-1 Inked immunosorbent assay was 
used to analyze the polyclonal antibodies collected from 
blood serum. All eight mice produced antibodies which 
showed specificity for the methoprene immunogen. 
vi I 
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Chapter 1. 
I ntroduction 
1.1. Uses of an Immunoassay for Methoprene 
The need for a quantitative assay to quantify 
methoprene, an insect growth regulator with juvenile 
hormone activity, is apparent when one considers the many 
uses of methoprene in the field. Field residue detection 
is becoming Increasingly important as government 
regulation and public scrutiny place more and more 
restrictions on pesticide residue levels (Brosten, 1987). 
Immunological assays for pesticides would allow sensitive 
and economical detection of residues. These assays have 
been only recently developed for detecting pesticides. 
To my knowledge, an immunoassay for methoprene is not 
available, despite the fact that methoprene has been used 
to control several insect pests. 
Methoprene is also widely used as a research tool to 
Investigate juvenile hormone-1 Ike activities in insects 
(Staal, 1975). Recent studies on receptor proteins using 
radiolabeled juvenile hormone and methoprene analogs, 
found them binding to different receptor sites 
(Prestwlch, 1987). An Immunoassay for methoprene could 
be used to Investigate the roles of methoprene in vivo. 
This thesis has developed immunological methods 
which will facilitate the detection and quantification of 
1 
2 
Figure 1. The chemical structure of methoprene, the five 
naturally occuring Juvenile hormones, and Juvenile 
hormone dIoI. 
Methoprene 
1 
1 
Juvenile Hormone I 
Juvenile Hormone IX 
A 
Juvenile Hormone III 
5 
Juvenile Hormone 0 
4-Methyl Juvenile Hormone I 
Juvenile Hormone I Diol 
4 
methoprene (1) (Figure 1). It is hoped that similar 
protocols can then be appI led to generate antibodies for 
the structurally related juvenile hormones, and other 
non-immunogenic materials, facilitating their detection 
and quantification. Existing immunological techniques 
for the juvenile hormones are laborious, expensive, not 
readily available, and at times unreproducIbIe or their 
results are in conflict with those obtained by physical- 
chemical methods. 
The main goal of this work was to covalently link 
methoprene to a protein and to use the resulting 
conjugate to produce specific polyclonal antibodies 
against methoprene. The antibodies produced would be 
used to develop immunological assays in the form of 
enzyme-Iinked immunosorbent assay (ELISA) or 
radioimmunoassay (RIA). ELISA and RIA have been 
developed for numerous substances, including chemicals 
with insecticidal activity, steroids, peptides, proteins, 
and viruses. These assays are fast, specific, and 
sensitive in their detection of minute quantities of 
materials of agricultural, environmental, industrial, and 
medical Importance. Protocols and procedures of the 
Immunological techniques developed for methoprene (1), 
will, hopefully, provide Insight on the development of 
similar techniques specific for the Juvenile hormones 
(structures 2, 3, 4, 5 and 6, Figure 1), and, thus, would 
greatly facilitate research on Juvenile hormone and 
Juvenile hormone related compounds. 
5 
Since methoprene is a small molecule, which does not 
arouse an Immunological response. It must be covalently 
bound to a large molecule, such as a protein, to form an 
Immunogen which can then elicit Immune responses. The 
protein acts as a carrier for the small molecule 
(hapten), which together challenge the immune system to 
produce antibodies against the hapten. 
1.2. Immunogens Prepared for the Juvenile 
Hormones 
The first attempts to conjugate Juveni le hormone I I I 
(4), which Is structurally related to methoprene (1), to 
a protein relied on converting Juvenile hormone to its 
acid form, derivatlzlng the acid to an active ester with 
N-hydroxysuccInImde and coupling the ester to human serum 
albumin (HSA) through an amide bond (Figure 2a) (Lauer et 
al., 1974a; Baehr et al., 1976). The resulting 
immunogen, illustrated by the model 9, where the triangle 
represents the epoxy function, the rectangle is the 
parent molecule, the hexagon is the ester function, and 
the circle represents the bulky protein molecule, has 
lost the ester function of the hormone. Antisera raised 
to this juvenile hormone immunogen recognized both 
Juvenile hormone III (4) and Juvenile hormone III acid 
(8) . 
Another effort conjugated Juvenile hormone I (2) to 
a protein through Its diol derivative (7), which was 
formed by opening the epoxide ring at carbons 10 and 11, 
Figure 2. The 
been prepared 
vIsuaI I zed by 
I I I Immunogen 
(4) and retains the 
Baehr et a I , 1976). 
various Juvenile hormone Immunogens have 
by different Intermediates and can be 
dIfferent mode Is. a: The Juvenile hormone 
(9) was made with Juvenile hormone III acid 
epoxide function (Lauer et al, 1974a; 
b: The immunogen (10) prepared from 
Juvnelle hormone I diol (7) retains the ester function of 
2, whIle IncorporatIng a four carbon spacer group between 
the diol and the protein (HSA) (Strambi et al., 1981). c: 
The proposed Immunogens for Juvenile hormone I (12 and 
14) (Eng and Prestwich, 1986) would be prepared from the 
intermediates 11 and 13 and would retain both the epoxide 
and ester functions of Juvenile hormone I (2). 
HO^ R, 
o 
« ' Q 
12 
11 
8 
(Figure 2b) (Strambl et al., 1981). This Immunogen 
(10) contains the ester function of the hormone, but not 
the epoxide. A spacer group, represented by the thick 
line In the model, was incorporated into the structure of 
the immunogen. The antisera raised against the immunogen 
(10) recognized only dlol derivatives of the juvenile 
hormones. No antiserum reported solely recognizes 
juvenile hormone. Eng and Prestwhich (1986) have 
proposed immunogens for Juvenile hormone (12, 14) where 
the hormone would be I Inked to a protein via a hydroxyl 
group as depicted In Figure 2c (compounds 12 or 13), thus 
maintaining both functional ends of the hormone. 
1.3. Design of an immunogen for Methoprene 
Based on the results from Juvenile hormone 
radioimmunoassays, it was apparent that a useful 
immunoassay for methoprene would have to be: a) specific 
for the methoprene molecule in its native form; b) 
sensitive to quantities of methoprene in the nanogram to 
picogram range; c) able to be used with a minimum of 
sample purification and prepartion; d) reproducible, such 
that different laboratories could compare results; and e) 
in agreement with the results obtained from physical- 
chemical methods for similar samples. 
The design of the methoprene Immunogen was proposed 
to meet the above criteria. The production of specific 
antibodies against methoprene is dependent on the ability 
of an animal's immune system to "see" methoprene in its 
9 
"native" form. To allow better recognition of the 
methoprene derivative on the surface of its protein 
carrier, a spacer chain was incorporated between 
methoprene and the protein. The spacer serves as a 
flexible linker between methoprene and the protein, thus 
reducing steric hindrance between the two. By choosing 
the proper spacer incorporation and protein conjugation 
scheme, the immunogen retained both the ester and methoxy 
moieties of the methoprene molecule. The structure of 
the prepared Immunogen (16) Is Illustrated in Figure 3. 
To encourage the detection of methoprene in its 
native form In the animal, its ester function was 
retained in the derlvatized methoprene molecule by 
coupling It to the spacer group as an ester. This served 
two purposes: a) an ester function, which is native to 
methoprene. Is In the same post Ion; and b) the ester 
a I lowed for the Incorporation of a spacer between 
methoprene and the protein carrier. The spacer group is 
depicted by the thick line in the immunogen model 16 (p. 
11). 
Previous attempts at preparing immunogens for 
Juvenile hormone have always destroyed one of the 
functional groups of the Juvenile hormone molecule. The 
immunogen prepared from Juvenile hormone acid (9) (Lauer 
et al., 1974a; Baehr et al., 1976) lacked the ester 
function, but contained the epoxide. The immunogen 
Figure 3. The methoprene Immunogen (16) was prepared from 
methoprene (1)» which had been modified to incorporate a 
four carbon spacer group with a carboxylic acid function 
(15). The resulting immunogen retains both the methoxy 
and ester functions of methoprene. 

12 
prepared from Juvenile hormone dlol (10) lacked the 
epoxide moiety, but contained the ester (Strambl et al . , 
1981). Two additional immunogens for juvenile hormone 
(12 and 14) were proposed (but not prepared) by Eng and 
Prestwich (1986), In which the functionalities of both 
ends of methoprene will be retained. The Immunogen 
prepared for methoprene (16) also contains the 
functionality of both ends of the molecule. By our 
design, a bridge (spacer) between methoprene and the 
bulky protein molecule allows for the maintenance of both 
the ester and the epoxy functionalities (Figure 4). 
The incorporation of the spacer group required a 
number of protect I on-deprotect I on steps (Figure 5) and 
Insure that reactions occured mostly between selected 
functional groups as Intended. Such precautions reduced 
the possibility of unwanted side reactions. Specific 
reagents and conditions were employed to remove the 
protecting groups so that functional groups (i.e. esters, 
double bonds, and methoxides) were not affected. 
Two other problems might be anticipated: a) 
differential solubility of hapten (lipid) and carrier 
(protein) In the reaction mixture, and b) the monitoring 
of the extent of the coupling reaction. Methoprene, 
which has a long hydrocarbon chain, is extremely 
insoluble in aqueous solutions (1.39 ppm. Farm Chemicals 
Handbook, 1987). Its solubility Is greater in organic or 
polar organic/aqueous solutions. Proteins, however, are 
Figure 4. The Immunogens for Juvenile hormone and 
methoprene have various characteristics In common. Only 
the methoprene Immunogen (16) has all the functionalities 
of the native molecule (1), In addition to having a 
spacer group between methoprene and its protein carrier. 
See figures 2 and 3 for explanation of symbols. 
14 
15 
figure 5. The four carbon spacer group was incorporated 
between methoprene and a carrier protein by a series of 
protection, deprotection, and coup I ing reactions. This 
synthetic route insured that the desired products were 
formed, minimizing unwanted side reactions. 
H 
i 
0oA^s^>® 
1 
© 
1 
HSA-NH2 ♦ H 
l 
HSA 
H 
GD G>f * prot®cti,n® cf°up 
17 
very water soluble, but their solubility decreases 
greatly in organic/aqueous solutions. Difficulties arise 
when one attempts to solubiIize methoprene and a protein 
In a single solvent. 
To monitor the extent of the methoprene-protein 
coup I ing reaction, it Is necessary to either use a 
radiolabeled tracer or a spectrophotometric method to 
quantify the number of molecules of methoprene coupled 
per molecule of protein. A number of methods were used 
In this study (see Results section 4.4 and 4.5). 
It is hoped that this work will develop a new 
technique for methoprene quant Ifi11 on, and will shed new 
light on the improvement of present immunological 
techniques available for Juvenile hormone quantification. 
Chapter 2. 
Literature Review 
2.1 Role of Juvenile Hormone in insects 
e 
The physiological and developmental events In 
Insects are control led by a hormonal system responding to 
internal and external cues. There are five major 
hormones responsible for integrating growth and 
development: juvenile hormone; prothoracI cotropIc 
hormone; ecdysone, eclosion hormone; and bursicon. This 
integration Is illustrated In Figure 6. Briefly, 
Juvenile hormone, a sesquiterpene epoxide, has a variety 
of roles in the life processes of Insects. 
ProthoracIcotropic hormone, a peptide hormone, is 
secreted by the brain and Is responsible for stimulating 
the prothoraclc or ecdyslal glands to produce a steroid, 
ecdysone. Ecdysone, the molting pre-hormone, is 
converted to 20-hydroxyecdysone by the epidermis, causing 
the secretion of new cuticle by Immature insects. 
Eclosion hormone, a neurosecretory product. Initiates 
preeclosion and eclosion behaviors which free the Insect 
from Its old cuticle. Bursicon, another peptide 
neurosecret I on, Is responsible for the tanning and 
strengthening of the new cuticle. These five hormones 
maintain the delicate internal environment necessary for 
successful growth and development in Insects. 
Juvenile hormone is, thus, of major importance to 
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There are five the growth and development of Insects, 
homologous forms of Juvenile hormone In Insects. They 
are all in the form of methyl esters of sesquiterpene 
epoxides (Figure 1). Much data has been gathered 
concerning the variety of physiological processes 
controlled by juvenile hormone. A few of the processes 
are metamorphosis, reproduct I on, behavior, diapause, and 
caste determination. 
2.1.1. Control of metamorphosis 
In order for an Insect to grow, it must periodically 
shed its old cuticle, forming in the process, a larger 
cuticle Into which It can expand. Throughout an insect's 
Mfe, different types of cuticle are produced. In 
species which undergo complete metamorphosis, larval 
cuticle Is made during larval stages; pupal cuticle is 
made at the end of larval development; and adult cuticle 
is formed as a result of metamorphosis in the pupal 
stage. The molting hormone, 20-hydroxyecdysone, controls 
the synthesis of the cuticle. The presence of Juvenile 
hormone at the critical period before each molt has the 
role of directing the nature of newly formed cuticle, or 
the nature of the molt: larval to larval; larval to 
pupal, or pupal to adult (Figure 6). 
Juvenile hormone is present at precise times during 
Figure 6. The classical scheme of Juvenile hormone and 
ecdysone action. Eel os I on hormone initiates behaviors 
necessary for old cuticle removal at each molt. Bursicon 
aids in the tanning of new culticle. (Redrawn from 
Gilbert and Schniederman, 1961). 
BRAIN 
neurosecretory CELLS 
CORPUS CARDtACUM 
CORPUS ALLATUM 
PROTHORACIC 
Gland 
cuticle 
f I V 
. • /•*•’. *••*• 
• • • * J . » * ' « * 
.* *.-• T t * * • 
. • ,< chromosome s • .*' 
♦ • j-.-' 
• ‘.V • Anaili •/*.••• 
.* « , X* •••*•• 
, • • ▼ 
V protein synthesis • 
• • * • •. • • 1 • , • . • 
# • • • • . t • 
• .■ larval STRUCTURES*' 
' • . \ .* . / « « “ . * m • 
V"' 
'T 
• chromosomes . 
4 '• 
• W- RNAIPI : v.. ' 
-J 
protein ^synthesis 
; PUPAL STRUCTURES 
( *.>V\ • • 
\- - _ _ .. » 
l 
LARVA 
chromosomes '• 
V * • HNAIAI 
••• *j-v 
PROTEIN SYNTHESIS 
\ 
AOULT STRUCTURES 
PUPA 
AOULT 
22 
larval life. A considerable level of Juvenile hormone In 
the hemolymph is maintained at the critical period with 
each successive larval Instar, until It is undetectabIein 
the last larval instar. This decline allows the insect 
to undergo metamorphosis (WiggIesworth, 1960; Van der 
Kloot, 1961). Declining juvenile hormone titer was also 
found to stimulate the synthesis of major hemolymph 
proteins by the fat body In the last larval and pupal 
stages In the silk moth, Bombyx morI (Plantevin et a I . , 
1987). During pupal development, the juvenile hormone 
titer declines and remains at a low level for the rest of 
metamorphosis. It rises again in the adult where it is 
Involved in the regulation of reproduction (Gilbert and 
SchneIderman, 1961). 
2.1.2. Reproduction Regulation 
The role of Juvenile hormone as a modulator of 
developmental processes Is further expanded In adult 
female Insects. Juvenile hormone has been shown to 
control the synthesis and/or uptake of egg precursor yolk 
proteins In many species of insects. The precursor yolk 
proteins, known as vitellogenins, are synthesized by the 
insect fat body (with some exceptions), released into the 
hemolymph and taken up by developing oocytes. 
Juvenile hormone controls the synthesis of 
vitellogenins by the fat body. Vitellogenin synthesis is 
prevented In locusts whose corpora allata, the primary 
source of Juvenile hormone, have been removed soon after 
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adult emergence. VI tel logenln synthesis may be Induced 
In allectomlzed females by topical application of 
Juvenile hormone I or methoprene (Chen et al., 1976). 
Fat body removed from a I lectomized females will produce 
mRNA's specific for the vitellogenin proteins after 
treatment with juvenile hormone I or methoprene. These 
ln vitro studies by Chen et al. (1976) demonstrate the 
action of juvenile hormone at the cellular level, where 
specific proteins are made by cells responding to an 
endocrine signal. An analogous system has been found in 
cockroaches (Englemann, 1974). The control of 
vitellogenin synthesis by Juvenile hormone in the fat 
body of adult female Insects provides a system for 
biochemical and modular study of hormonal control of gene 
expression (for reviews see Englemann, 1983; Koeppe et 
al., 1985; Rlddlford, 1985). 
The control of yolk protein synthesis In the 
mosquito demonstrates a different role for Juvenile 
hormone In reproduct I on. In the mosquito, Aedes aegypt I 
an Increase in Juvenile hormone titer after adult 
emergence causes growth of the oocytes before 
vitellogenin uptake (Shapiro, 1986). The increase In 
Juvenile hormone levels prepares the mosquito for blood 
meals which are required for egg development. As 
Juvenile hormone levels drop off after a blood meal, 
ecdysone levels increase, stimulating the synthesis of 
vitellogenin by the fat body (Hagedorn et al., 1979). 
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2.1.3. Control of Insect Behavior 
The endocrine system In Insects plays an important 
role In the control of behavior. It provides an economic 
means of obtaining a rich behavioral repertoire within 
the limited capacity of the insect central nervous system 
(Riddlford and Truman, 1974). Juvenile hormone has the 
effect of coordinating many behaviors In Insects, 
including reproductive behavior, migratory behavior, and 
foraging behavior. Reproductive behavior must coordinate 
a series of activities which are designed to ensure the 
fertilization of the gametes. The presence of juvenile 
hormone has been shown to regulate the sexual behavior of 
the female cricket, Acheta domestIcus (Koudele et al., 
1987). The phonotactic responsiveness and copulatory 
readiness of females were greatly reduced after 
allatectomy. Topical application of Juvenile hormone III 
fully restored these sexual behaviors. Juvenile hormone 
also controls sexual receptiveness of the female 
grasshopper, Gomphocercus rufus (Chapman, 1982). 
Allatectomy of the male grasshopper, Schlstocerca 
gregarI a, resulted in reduced protein synthesis In the 
male accessory gland. Inhibition of yellow coloration, 
and cessation of mating activity (Pener, 1965). 
Migratory behavior Is regulated, in part, by 
Juvenile hormone. Most insect species which migrate do 
so by flying as adults, before the onset of reproduction. 
In the milkweed bug, monarch butterfly, and Colorado 
potato beetle, flight behavior Is stimulated by 
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intermediate titers of juvenlle hormone (for reviews see 
Rankin, 1978; and Pener, 1985). Short days and poor food 
quality Induce intermediate Juvenile hormone levels In 
these Insects. Such conditions mimic the autumn season, 
where migratory fIights are observed and most of these 
insects are forced to forage farther for resources. 
Foraging behavior In honey bees may be Induced by 
Juvenile hormone. Worker honey bees perform a number of 
behaviors during adult life. Including cell cleaning, 
brood nest care, food handling, and foraging. These 
behaviors are spaclally segregated, where the youngest 
workers perform cell cleaning In the center of the nest; 
and the oldest workers engage in forging away from the 
nest. Topical application of methoprene or synthetic 
Juvenlle hormone I (Robinson, 1985) caused young worker 
bees to engage in foraging fIights much sooner than 
untreated bees. Africanized honey bees forage at a 
significantly younger age than European bees (Winston and 
Katz, 1982); however. Juvenile hormone hemolymph 
concentration did not significantly differ from European 
bees (Robinson, et al., 1987). Environmental conditions 
may modulate Juvenile hormone concentration, which may 
enable a honey bee colony to regulate Its division of 
labor In preparation for unfavorable conditions. 
2.1.4. Control of Diapause 
Environmental conditions rarely allow insects to 
sustain continuous development throughout the year. Many 
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insect species enter a period of diapause, where low 
metabolic rates enable them to stretch their food 
reserves to bridge the unfavorable period. In species 
which diapause in the larval stage, there is clear 
evidence that the brain regulates diapause induction. 
The brain integrates environmental information with the 
synthesis and release of hormonal products from the 
prothoracic gland, ecdysone, and the corpora allata, 
Juvenile hormone. 
In response to short days and cool temperatures, 
diapause Is initiated In the last larval instar of the 
southwestern corn borer, DIatraea grand IoseI I a. A drop 
in the hemolymph ecdysteroid titer and an increase in 
Juvenile hormone titer is required for diapause 
(Chippendale and Yin, 1976). The diapause state is 
maintained by high levels of Juvenile hormone. Removal 
of the corpora allata causes most larvae to terminate 
diapause and pupate within 30 days. Application of 
Juvenile hormone to a I IatectomI zed larvae prolongs 
diapause (Yin and Chippendale, 1979). The presence of an 
intermediate level of Juvenile hormone in these 
diapausing larvae appears to inhibit production of 
prothoracI cotropIc hormone by the brain (Sehnal et al., 
1981). Production of ecdysone by prothoracic glands and 
declining Juvenile hormone titers can terminate diapause 
(for review see Den I Inger, 1985). 
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2.1.5. Caste Determination 
The term polymorphism is used to describe 
individuals in a species with distinct but dissimilar 
external characteristics. Many different forms may be 
found within an Insect species. They may consist of 
larvae, pupae, and adults, and adult males and females 
may differ. In some species adults of the same sex may 
be differentiated by division of labor. A hierarchy of 
tasks divides the social Insects such as termites, bees, 
and ants into morphologically different Individuals 
within a colony of the same species. Caste formation is 
under the control of juvenile hormone. In lower 
termites, high juvenile hormone levels topically applied 
to nymphs are required for the the production of 
soldiers, while very low juvenile hormone titers in 
nymphs allow them to develop Into supplementary 
reproduct Ives (wingless reproductive adults) (Hardee and 
Lees, 1985). In higher termites an egg laying queen 
produces large amounts of Juvenile hormone, some of which 
is passed on to developing nymphs through anal 
secretions. High juvenile hormone titers prevent the 
production of reproduct Ives, In favor of the neuter 
caste. If the reproducing male and female, the royal 
pair, are removed from the colony, new reproduct Ives are 
formed. For a complete review of the role of Juvenile 
hormone in caste determination see Hardle and Lees 
( 1985) . 
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2.2. Quantification of Juvenile Hormone 
The importance of juvenile hormone during the life 
span of an insect Is apparent from the above discussion. 
Juvenile hormone titers change frequently throughout an 
insect's life, thus allowing for an integrated control of 
the Insect's physiological needs. To understand the 
endocrinology Involved, accurate and precise methods of 
measuring Juvenile hormone titers at different stages in 
the insect life cycle are necessary. Juvenile hormones 
may be extracted from insect tissues and fluids; however, 
the physiological concentration of the hormone is quite 
small. In the range of 10-9 to 10~12 M (Mauchamp et al., 
1984). The smaI I amount of Juvenl le hormones present 
along with interfering endogenous organic materials make 
the quantification of Juvenile hormones difficult. 
Early methods of Juvenile hormone quantification 
relied on indirect chemical and biological assays which 
provided Information on the relative activity of the 
corpora allata, but were qualitative at best. Biological 
assays have, for the most part been replaced by more 
direct assays, which Include radiochemical assays, 
physIcaI-chemIcaI methods and radioimmunoassays. 
2.2.1. Bioassays for Juvenile Hormone Detection 
The detection of juvenile hormone by bioassay relies 
on the response of a whole or part of another Insect 
body. Juvenile hormone or samples which may contain 
Juvenile hormone are applied to the test animal or 
tissue. Juvenile hormone activity Is determined as the 
degree of inhibition of metamorphosis of the test animal. 
One of the most widely used bioassays, the Gal IerI a 
wax moth test (see Yin and Chippendale, 1976), uses newly 
mo,ted Gal IerI a me I I one I I a pupae. Newly molted pupal 
cuticle is extremely responsive to Juvenile hormone. 
Juvenile hormone presence In a test sample is determined 
by Inhibition of pupal-adult metamorphosis of the treated 
tissue. Verification of this method by electron capture- 
gas chromatography showed that Juvenile hormone titers in 
whole body extracts of the southwestern corn borer could 
not be estimated with the GaI Ieria bioassay due to 
Interfering substances (Bergot, et al., 1976). However, 
both the bioassay and the chromatographic method could be 
used to estimate Juvenile hormone titer In the hemolymph 
of the southwestern corn borer (Bergot at al., 1976). 
GaI IerI a wax test has also been used to demonstrate 
Juvenile hormone activity In larvae (Blight and Wenham, 
1976) and adult male of SchIstocerca gregarI a and Locusta 
mIgratorI a (Johnson and HIM, 1973). 
Other bloassays for Juvenile hormone Include tissue 
culture, larval cuticle pigmentation, and metamorphosis 
Inhibition of whole Insects. Cultured Integumental 
tissue of the rice stem borer, ChI lo suppressaI Is 
(Kitahara, 1983), or the tobacco hornworm, Manduca sexta 
(Riddlford, 1975), failed to undergo larval-pupal 
30 
metamorphosis in the presence of juvenile hormone. 
Estimation of Juvenile hormone titers In the hemolymph of 
Manduca sexta was determined by a black mutant larval 
pigmentation assay where Juvenile hormone prevented 
melanizatlon of the black mutant larval cuticle. (Fain 
and Rlddiford, 1975). Bloassays for insect growth 
regulators with Juvenile hormone activity have been 
developed using inhibition of metamorphosis of a number 
of economically important insects including: the house 
fly, pea aphid, tobacco budworm, greater wax moth, yellow 
meal worm, and the yellow fever mosquito (Henrlck et al., 
1973; Henrlck et al., 1975). The effectlvness of the 
insect growth regulator was measured as a function of the 
percentage of insects unable to molt to their next 
developmental stage. 
Although the above assays indicate the presence of 
Juvenile hormone and some of them may be very sensitive 
(detecting plcogram levels of the hormone), they fall to 
distinguish between the different Juvenile hormone 
homologs. They also lack prescision In that the exact 
quantity of Juvenile hormone In a sample Is difficult to 
assess, paricularly when Interfering substances may give 
false results. If a quantitative measure of Juvenile 
hormone Is to be obtained, the bloassay must be coupled 
with a physIcaI-chemIcaI analysis. 
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2.2.2. Radiochemical Assay for Juvenile Hormone 
Biosynthesis 
Since bloassays were found to be, at best, 
qualitative, some researchers have developed assays which 
measure the J_n vitro biosynthesis of Juvenile hormone. 
The realization that the corpora allata produce and 
secrete juvenile hormone In Insects has led to techniques 
which allow the hormones to be extracted from media In 
which active glands are placed. Ear.ly work by Judy et 
ai. (1973) enabled the In vitro Incubation of the corpora 
allata In a commercial medium containg no methionine. 
Radiolabeled L-[methyI-14C] methionine was added to the 
medium to act as a labeled donor for the IncorproatI on of 
the methyl ester moiety of Juvenile hormone. The 
Incubated gland synthesized 1^C-JuvenI Ie hormone Into the 
surrounding medium. The medium was then extracted and an 
estimate was made of the amount of juvenlle hormone 
bIosynthesI zed by the glands. Subsequent use of high 
pressure liquid chromatography (HPLC) and gas 
chromatography-mass spectrometry further Identified the 
nature of the Juvenile hormones produced j_n vitro. The 
radiochemical assay shows a sensitivity of 0.1 pmoI when 
14C-methyI-methI on Ine Is used as the methyl donor in 
Juvenile hormone biosynthesis. A number of reviews and 
reports document the data obtained by the in vitro 
radiochemical assay for Juvenile hormone biosynthesis 
(Tobe and Feyereisen, 1982; Pratt, 1984; Tobe et al., 
1984; Tobe and Stay, 1985). 
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2.2.3. Phys1caI —chemicaI Methods for Juven1 le Hormone 
Quant 1f1 cat I on 
One of the most rapid, sensitive, and specific 
methods for Identification and quantification of Juvenile 
hormones from Insect tissues Is the use of physical- 
chemical methods, such as gas chromatography—mass 
spectrometry (GC-MS) or hIgh-performance Iiquld 
chromatography-mass spectrometry (HPLC-MS). To use such 
techniques, a few requirements are needed. First, access 
to such equipment and expertise Is necessary. Second, 
Insect tissues must first be purified chromatograph IcaI Iy 
to remove Interfering substances, and third the Juvenile 
hormones must be derivatlzed before they can be analyzed 
by gas chromatography. PhysIcaI-chemIcaI techniques 
offer verification and validation of the various assays 
used for Juvenile hormone quantification. 
To prepare the Juvenile hormones for GC analysis, 
micro-derivatizatIon reactions are used to convert the 
epoxide ring of the Juvenile hormones to from their 
respective methoxy hydrins, which are converted to their 
11-methoxy-io-pentafluorophenoxy acetate esters. These 
esters may then be subjected to gas chromatography. 
Early work used gas chromatography coupled with electron 
capture detection to quantitatively measure the Juvenile 
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hormone biosynthesis from J_n vitro incubation of the 
corpora ailata (Schooley et al., 1975) or Juvenile 
hormone titer on hemolymph or whole body extracts (Bergot 
et al.,1976). More recently, the addition of mass 
o 
spectrometry to gas chromatographic analysis has 
simplified and shortened of derI vatizatI on procedures; 
enabled the use of smaI I sample sizes, and produced a 
level of sensitivity of less than 0.01 ng/ml. These 
methods have provided precise determination of Juvenile 
hormone titers In a number of insects species (Bergot et 
al., 1981a; 1981b; RemboId, 1981; de Kort et al., 1982; 
Mauchamp et al., 1984; Schooley et al., 1984; Shapiro, 
1986), and identification of Juvenile hormone analogs 
from embryonic stages of Manduca sexta; Juvenile hormone 
0 and 4-methyl juvenile hormone I (Figure 1) (Bergot et 
al., 1980; Bergot et al., 1981c). 
High-performance liquid chromatography (HPLC) has 
also been used extensively to purify the Juvenile 
hormones from Juvenile hormone metabolites In biological 
samples prior to analysis by radioimmunoassay (Granger et 
al., 1979). However, since Juvenile hormone 
concentrations In biological samples are too low to be 
detected by direct UV analysis, a system was developed 
which coupled HPLC to mass spectrometry (HPLC-MS) 
(Mauchamp et al., 1981). This system allowed direct 
quantification of biologlgal samples. This method 
required two prepurification steps-of the samples to be 
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analyzed. Elutulon on a glass packed alumina column Is 
first required, followed by filtration through a C-jg Sep- 
pakR cartridge (Waters Associates). The eluent is then 
analyzed with the HPLC-MS system. 
The data collected by physicaI-chemIcaI methods 
coupled to mass spectrometry are clearly more accurate, 
reproducible, and may be the best method for juvenile 
hormone quantification. The major advantages of these 
methods are their high sensitivity and the reduction of 
time required for analysis. The expense and availability 
for such analyses, however, may be problematic for many 
IaboratorIes. 
2.2.4. Radioimmunoassays for Juvenile Hormone 
Quant IfI cat I on 
Radioimmunoassays have been successfully used to 
quantify hormones in biological samples from both 
vertebrate and Invertebrate systems. They are generally 
sensitive, with detection Iimlts In the nanogram to 
picogram range, reproducible, and simple to use with a 
minimum of sample preparation. Radioimmunoassays for 
Juvenile hormone have been reported, however, their 
effectiveness has been limited due to the physical nature 
of the Juvenile hormones, the presence of Juvenile 
hormone homologs, degradation products, and interfering 
substances in the samples to be analyzed. 
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juvenile hormone is a small, hydrophobic molecule, 
with poor solubility In aqueous solutions (Giese et al., 
1977). In order for Juvenile hormone, (or methoprene) to 
become immunogenic, it must be conjugated to a large 
carrier molecule such as a protein. To do this, juven.ile 
hormone must be modified to make functional groups 
available for reaction with the protein. Two methods of 
juvenile hormone modification have been reported thus 
far: a) the hydrolysis of the methyl ester to form a 
carboxylic acid (Figure 2a); and b) the opening of the 
epoxide ring to form the diol (Figure 2b). A third 
method of conjugating Juvenile hormone has been proposed, 
but no results have been reported (Eng and Prestwich, 
1986). This last method would retain both the epoxy and 
carboxy moieties (Figure 2c). Antibodies have been 
raised against immunogens prepared by methods (a) and (b) 
and have been used In the quantification of Juvenile 
hormone In biological samples. 
2.2.4.1. Conjugation of Juvenile Hormone via the 
Carboxylie Acid 
Lauer et al. (1974a) described the preparation of a 
Juvenlle hormone Immunogen by conjugating the hormone to 
the protein, human serum albumin (HSA). This method was 
further expanded by Baehr et al. (1976). In both 
methods, mild alkaline conditions were used to hydrolyze 
the methyl ester (17) to the acid (18) (Figure 7a), which 
Figure 7. Synthetic scheme for the preparation of an 
immunogen and an iodinated tracer from Juvenlle hormone 
acids. 
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was then coupled to N-hydroxysuccInImide (NHS) to make 
the activated ester (19) using the reagent 1,3- 
dieye IohexyI carbodi ImIde (DCC) (Figure 7b). Free lysine 
groups on the protein were reacted with the activated 
NHS-ester (19), conjugating Juvenile hormone to the 
protein through an amide bond (20) (Figure 7c). 
Spectrophotometric estimation of the number of juvenile 
hormone residues per molecule of protein gave 20 (Lauer 
et al., 1974a) and 26 (Baehr, 1976).' A radiolabeled 
tracer (21) was also prepared for subsequent 
characterization of the antibodies raised against the 
immunogen (20). The activated NHS-ester (19) was reacted 
with histamine and then rad IoIodinated with chloramine T 
\\ 
to give a specific activity of 2000 cI/mmoI (Figure 7d). 
Immunogens were prepared In this way for the 
Juvenile hormone homo logs, Juvenile hormone I, II, III, 
and were used to raise high titer polyclonal antibodies 
against each of them. These antibodies reacted 100% with 
their respective juvenile hormone acids, and cross 
reacted with other analogs to a lesser extent (Table 1). 
The first antibody produced (Lauer et al., 1974a) showed 
low binding affinity for Juvenile hormone III (33 ug/ml 
assay for 60% displacement). The antibody generated by 
Baehr et al. (1976) had Improved sensitivity (1.5 ng/ml 
for 50% displacement). Using antisera from the same 
source, Granger et al. (1979; 1982) reported affinities 
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Table 1. Reactivities and cross reactivities of antisera 
raised against Juvenile hormone Immunogens I, II, and 
III. 
Hormone/ana1og JH 1 
React 1v1ty and 
Cross-react Iv1ty 
JH 1 1 
(%) 
JH 1 1 1 
A B C D E F 
JH 1 100 100 16.7 26 0.6 
JH 1 1 37 12.6 — 100 0.9 60 
JH 1 1 1 0.4 1.7 — 12 100 100 
JH O — 37 — — 0.6 — 
JH 1 ac 1 d 60 100 — — — — 
JH 1 II acid — — — — 77.1 — 
JH 1 d lol 14 0.6 100 — — — 
JH 1 1 dlol — — 100 — — — 
JH 1 II dlol ” — — — 100 — — 12.0 —• — 
A: Baehr et a I . ( 1976). 
B: Granger et al. (1979). 
C: StrambI et a I . (1981). 
D: Baehr et al., (1981). 
E: Granger et al. (1982). 
F: Lauer et al. (1974a). 
for Juvenile hormone I and III of 1.2 and 1.0 ng/ml, 
respectively, for 50% displacement. The antisera raised 
against juvenile hormone II by this method (Baehr et al., 
1981) had high cross reactivity against both Juvenile 
hormone I and III (Table 1), and has not been used to 
develop radioimmunoassays. 
The antibodies raised against juvenile hormone I 
were used to develop a radioimmunoassay to study the 
biosynthesis of both Juvenile hormones I and II in day 5 
last Instar larvae of Manduca sexta (Granger et al., 
1979). A biosynthesis ratio of Juvenile hormones 1:11 
(1:4) was calculated from HPLC purified extracts of 
medium In which corpora a I lata were incubated. 
Granger et al. (1982) developed a radioimmunoassay 
for Juvenile hormone III, and quantified Juvenile hormone 
biosynthesis In the corpora allata of day 5 Manduca sexta 
larvae. Radioimmunoassay of HPLC-purIfied extracts In 
which corpora allata were Incubated gave a biosynthesis 
ratio of juvenile hormones 1:11:111 (1:3.6:2.2). Granger 
et al. (1979) claimed that the 1:4 ratio of biosynthesis 
of juvenile hormone 1:11 is conslstant with 
rad IochemIcaI-gas chromatograph Ic results reported for 
N 
day 5 Manduca sexta Iarvae by Dahm et a I. ( 1976). 
However, Dahm et al. (1976), detected no Juvenile hormone 
In larvae of this stage, and no reported values for 
Juvenile hormone biosynthsls have the ratio of 1:4 for 
any Manduca sexta stage tested. 
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Additional problems have arisen when the 
radioimmunoassay for Juvenile hormone 1 was used to 
quantify the Juvenile hormone content In the hemolymph of 
fourth and fifth instar Locusta mIgratorI a (Baehr et a I ., 
1979). High levels of Juvenile hormone I were found in 
both the fourth and fifth instar stage. When gas 
chromatography-mass spectrometry was used to identify the 
nature of Juvenile hormone in the L. mIgratoria , at the 
same developmental stages, only Juvenile hormone III was 
found (Bergot et al., 1981). Verification of the amount 
and nature of Juvenile hormone (In biological samples) by 
physIcaI-chemIcaI methods has not been reported by groups 
using the antisera prepared against Juvenile hormone acid 
immunogens (Granger et al., 1982; 1987; Bollenbacher et 
al . , 1987). 
2.2.4.2. Conjugation of Juvenile Hormone via the Epoxide 
The second reported method for a Juvenile hormone 
radioimmunoassay utilizes the epoxy moiety for the site 
of conjugation to a protein (Strambi et al., 1981). The 
epoxide ring of a mixture of Juvenile hormone I (2) and 
°H-Juvenile hormone I was opened to the diol (7) by 
treatment with acid (Figure 8a). The dlol (7) was then 
treated with succinic anhydride in the presence of base 
to form the hem IsuccInate (22) (Figure 8b), which was 
coupled to human serum albumin with 1-ethyl-3(3- 
dimethyI am InopropyI) carbodllmlde (EDC) (Figure 8c). On 
Figure 8. Synthetic scheme for the preparation of an 
immunogen and an iodinated tracer from juvenile hormone 
d i o I . 
a 
Immunogen Preparation 
Tracer Preparation d 
the basis of its radioactivity, the conjugate (23) was 
found to contain 17 molecules of succlnyl Juvenile 
hormone (22) per molecule of protein. An iodinated 
tracer (24) was also prepared by reaction of the juvenil 
hormone hemisuccinate (22) with gIycyI tyrosine, followed 
by iodination with 125l-lodide (Figure 8d). This tracer 
had a radioactivity of 2 x 105 counts min"1 ml"1 when 
diluted with a citrate-hemoglobin buffer. Antibodies 
raised against the diol Immunogen (23) had high 
specificity for the diol (7). 
The diol radioimmunoassay has three advantages 
(Strambi et al., 1981): a) the diol is more 
ImmunoreactIve than juvenile hormone; b) the diol Is more 
water soluble and less absorbed onto surfaces; and c) the 
diol is easier to separate from lipids which are the main 
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source of non-specific Interference In Juvenile hormone 
radioimmunoassays. Two major disadvantages of this 
radioimmunoassay are: a) the antibodies raised cannot 
distinguish between Juvenile hormone diol homologs (Table 
D; and b) all biological samples containing Juvenile 
hormones must first be converted to their respective dlol 
derivatives. This process entails lengthly extraction 
and purification procedures. Strambi et al. (1981) 
caution that the user should pay scrupulous attention to 
each step of the diol conversion so that the hormones are 
carefully purified and products are handled properly. 
Despite the need for care in sample handling and 
purification, the radioimmunoassay developed for juvenile 
hormone diols was used to quantify the Juvenile hormone 
titers in the hemolymph of the Colorado potato beetle 
(StrambI et a I ., 1984). The method was validated by 
physical-chemical analysis (de Kort et al., 1985). These 
results have encouraged the use of this assay for the 
determination of Juvenile hormone titers In Bombyx mor i 
(Piantevin et al ., 1987) and ApIs me I I Ifera (Robinson et 
a I . , 1987). 
2.3. Methoprene as an Insect Control Agent 
Juvenile hormone analogs are chemicals structurally 
related to Juvenile hormone. A Juvenold Is any chemical 
capable of showing the same physiological activity In an 
insect species as the native juvenile hormone, and may be 
capable of restoring normal Juvenile hormone-mediated 
functions In an a I IatectomI zed insect (Henrick, 1982). 
The Juvenile hormone analog and Juvenold, methoprene, is 
the most commercially advanced example of a class of 
compounds known as the Insect growth regulators (ICR's). 
Insect growth regulators interfere with the developmental 
processes of Insects and pose few undesirable effects on 
man, wildlife, and the environment. The development- 
interfering activity of methoprene has proven to be 
effective against some species of Insect pests with low 
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toxicity to non-target species and rapid degradation in 
the envIronment. 
Methoprene has been shown to have low toxicity to 
protozoa, annelids, molluscs, Crustacea, fish, 
amphibians, birds, and some non-pest insects such as 
damselflies, mayflies, and water beetles (Mlura and 
Takahashl, 1973). Mamma I I an toxicity to methoprene was 
very low, where no toxicity was found in rats given 
10,500 mg/kg (Siddall and Slade, 1974). In cattle [5- 
14C]-methoprene was metabolized to acetate and other 
labeled intermediates (Qulstad et al., 1975a). A large 
amount of the 14C-label was lost by respiration (14C02) 
in the cow and guinea pig (Chamberlain et al., 1975). 
The non-toxic effects of methoprene on mammals and some 
non-pest insects Is a welcome advantage compared with 
traditional insecticides. 
The life of methoprene In the environment Is 
limited. Methoprene has been shown to be very 
susceptible to photo lytic decomposition under 
enviromental conditions (Qulstad et al., 1975b). it is 
also metabolized by aquatic microorganisms (Schooley et 
al., 1975). The half Iife of 3H-methoprene in pond water 
containing unknown microorganisms was 30 h at a 
✓ 
concentration of 0.001 ppm. 
The Environmental Protection Agency has recognized 
the value of methoprene In pest control. Methoprene and 
another Juvenold, klnoprene, are registered by the Agency 
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for Insect control (Henrlck, 1982). Products In use 
Include a mosquito larvlclde (Altosld SR-10, Altosld 
Briquet), a horn fly larvlclde (Altosld 10-f and Bolus), 
a mushroom fly control agent (Apex), and a flea control 
agent (Precor). Methoprene was the first successful 
commercial appIIcation of a Juvenold on a stored product, 
tobacco (Menn, 1981). Henrlck (1982) lists many of the 
insect species which are susceptible to methoprene. 
2.4. Mode of Action of Methoprene 
Although Juvenolds have Juvenile hormone activity, 
their mode of action differs from that of Juvenile 
hormone Itself. The physiological activities Induced by 
both Juvenile hormone and Juvenolds are similar. Studies 
at the molecular level, however, show that Juvenolds have 
different binding sites than those of Juvenile hormone. 
High affinity Juvenile hormone I binding sites have 
been isolated from DrosophI I a larval integument (Klages 
et al., 1980). Methoprene and other Juvenile hormone 
analogs were found to be poor competitors for these 
binding sites in the presence of Juvenile hormone I. An 
125 
l-labeled derivative of methoprene (Boehm and 
Prestwlch, 1986) was also a poor competitor for Juvenile 
hormone receptor sites In Manduca sexta Integumental 
tissue. Indicating for the first time that there may be 
different receptor sites for both Juvenile hormone 
homologs and Juvenile hormone analogs (Prestwlch, 1987). 
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The molecular basis of action of dodecadIenoates with 
Juvenile hormone activity Is still unclear, but It may be 
postulated that once I Ipld molecules I Ike the Juvenlle 
hormone homo logs or analogs, bind to specific cellular 
receptors, the releasing mechanism for physiological 
action may be the same. The binding affinltes of 
cellular receptors may differ greatly. More study is 
needed on the mode of action of Juvenl le hormone homo logs 
and analogs. 
2.5. The Importance of Methoprene in the 
Development of Immunological Assays 
Though problems with Juvenile hormone 
radioimmunoassays exist, the merits of developing such a 
technique do not preclude its use as a means of juvenile 
hormone detection and determination. The value of 
Juvenile hormone radioimmunoassays has been demonstrated 
(Granger and Goodman, 1983; Gilbert, 1984; Tobe and Stay, 
1985; Eng and Prestwlch, 1986). Before data generated 
from juvenile hormone radioimmunoassays can be accepted, 
more work needs to be done on antisera generation and 
characterlzatIon, and assay validation. Care must be 
used when preparing samples and separating juvenile 
hormone homo logs from whole insect bodies or incubation 
media. The routine use of internal standards should be 
employed to monitor juvenile hormone recovery from any 
quantification method. The final test for a successful 
Juvenile hormone radioimmunoassay will be Its comparison 
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with data obtained from physIcaI-chemIcaI methods. 
Unless the assay has been proven unequivocally. It Is no 
longer enough to claim the presence and quantity of a 
Juvenile hormone homolog based on radioimmunoassay data 
a I one. 
To overcome the problems encountered with existing 
assays, the use of methoprene is proposed for the 
development of immunological assays. Each step in the 
preparation of the immunogen for methoprene has been 
documented with spectral data and radioisotope labeling 
where appropriate. The merits of methoprene as an insect 
control agent and a research tool are great, warranting 
its use as a model for the development of Immunological 
assays. The information and experience gathered here may 
help the development of other Immunological assays for 
other Juvenolds. 
Chapter 3 
Methoprene Immunogen Preparation 
3.1. Materials and Methods 
Methoprene, Isopropyl 11-methoxy-3,7,11-trImethyI - 
2,4-dodecadIenoate, and 5-14C-methoprene were gifts from 
Zoecon Corporation. 1,3-D I eye IohexyIcarbodI ImIde (DCC), 
4-(N,N-dImethyI)am I no pyridine (DMAP), sod I urn 
4-hydroxybenzene sulfonate dI hydrate, 
2-(trImethyIsllyI)ethanol, benzyl alcohol, 
4-butyroIactone, N-hydroxysuccInImIde (NHS), magnesium 
sulfate (MgS04), silver nitrate (AgN03), potassium 
phosphate monobasic (KH2P04), and farnesol, 3,7,11- 
trImethyI-2,6,1O-dodecatrIenoI, were obtained from 
Aldrich (Milwaukee, Wl). Sodium phosphate monobasic 
(NaH2P04) and sod I urn acetate were obtained from Baker 
(PhI I l |psburg, NJ). TetraethyIammonI urn fluoride (Et4F) 
was obtained from Kodak (Rochester, NY). Pyrldlnlum 
chIorochrornate (PCC) was prepared by the method of Corey 
and Suggs (1975). 
Solvents used were Fisher reagent grade. 
Tetrahydrofuran (THF) and acetonitrile (CH3CN) were 
distilled from calcium hydride. The mixture of hexanes 
used as a solvent was the petroleum distillate Skelly B 
(common name for a mixture of hexanes). Hydrochloric 
add (HCI), acetic acid (HOAc), sulfuric acid (H2S04), 
nltrlc acid (HN03), sod I urn bicarbonate (NaHC03), sod I urn 
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hydroxide (NaOH), potassium hydroxide (KOH), and hydrogen 
peroxide (H202) were also obtained from Fisher. Flash 
chromatography was carried out according to St I I I et a I. 
(1978) using technical grade solvents. Silica gel, 
Merck 230-400 mesh, 60 A, and silica gel coated glass 
plates, 60 A, were obtained from Aldrich. 
Bovine serum albumin (BSA), fraction V, and Freund's 
complete and Incomplete adjuvants were obtained from 
GIbco (Grand Island, NY). Human serum albumin (HSA, 
fraction V, fatty acid free), thlmersal (sodium 
ethyImercurIthlosaIIcyate), 2,2'-azI no(3- 
ethyIbenzthIazoI In suIfonate)-dIammonI urn salt (ABTS), 
Tween 20 (poIyoxyethyIenesorbI tan mono Iaurate), and goat 
antimouse horseradish peroxidase conjugated antibody were 
purchased from Sigma (St. Louis, MO). Trls 
(trI(hydroxymethyI) amlnoethane) was obtained from Bio- 
Rad (Richmond, CA). Dialysis tubing, molecular weight 
cut off 12,000-14,000, was obtained from Fisher. 
Turberculin syringes, 1 and 5 ml, were obtained from 
Becton-Dicklnson (Rutherford, NJ). Immulon 1, poly(v!nyl 
chloride) (PVC) wells were obtained from Dynatech Labs 
(Alexandria, VA). 
Liquid scintillation counting was done on a Packard 
Trl-carb spectrometer with scintillation counting medium 
(Aquasol li) from New England Nuclear (Cambridge, MA) . 
Values are reported in counts min-1 (cpm). Ultraviolet 
and visible spectrophotometrIc analysis were carried out 
,n a LKB Ultraspec 4050. Absorbances from enzyme linked 
Immunosorbant assays (ELISA) were read on a MR 600 
Microtltre Plate Instrument from Dynatech Instruments 
(Torrance, CA), and reported in optical density (O.D.). 
Infrared (IR) spectra were recorded on a Perkin Elmer 
1420 ratio recording spectrophotometer. The chart was 
calibrated against polystyrene (1601 cm-1). Proton 
nuclear magnetic resonance (1H NMR) was performed on 
either a 60 MHz Perkin Elmer R12A or a 200 MHz Varlan 
spectrometer. Chemical shifts (k) are reported in parts 
per million (ppm), down field from the internal standard, 
tetramethylsllane (k 0.0). All nmr and lr spectra may be 
found In Appendix A, page 138. 
Eight female, BALB/c mice were obtained from Charles 
River Breeding Labs (CambrIdge, MA). The mice were kept 
at 27°C on a diet of rat chow. 
3.2. Experimental Section 
The following sections describe the synthesis of all 
intermediates necessary for the preparation of an 
Immunogen for methoprene. 
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4-BenzyloxybutanoIc acid (28) 
A solution of benzyl alcohol (25) (27.12 g, 0.25 
m°l ) in "toluene (150 ml) was added slowly to sod I urn (5.75 
9. 0.25 mol) in xylene (50 ml). Upon completion of the 
addition, the mixture was heated to reflux for 4 h. 4- 
ButyroIactone (27) (21.51 g. 0.25 mol) was added and the 
solvent was removed by heating the mixture slowly at 
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220°C. The temperature was maintained at 220°C for 2 h. 
The mixture was cooled and the yellow solid was dissolved 
in water (300 ml), washed with diethyl ether (Et20) (2 x 
100 ml) and acidified with glacial acetic acid. The 
mixture was extracted with Et20 (3 x 200 ml), the 
combined extracts were dried (MgS04) and the solvent was 
removed. The residue was distilled to give 9.52 g (21%) 
of (28) (Figure 9a): bp 140°C/0.8 mmHg (150°C/2.5 mmHg, 
Sudo et al., 1967). 1H NMR (CDCI3, 200 MHz): k 1.8-2.1 
(m, 2H, 3-CH2), 2.50 (t, J = 7 Hz, 2H, 2-CH2), 3.55 (t, 
J ■ 6 Hz, 2H, 4-CH2), 4.03 (s, 2H, benzyI Ic-CH2), 7.25 
(s, 5H, phenyl). IR (neat): cm-1 3600-2400 (w, COOH), 
1710 (s, C=*0), 700, 750 (m, Ph). 
2-(TrImethyIsI IyI)ethyI 4-benzyIoxybutanoate (30) 
4-(N,N-DI methyI)am I no pyridine (DMAP) (0.73 g, 5.97 mmol) 
and 1,3-d I cyclohexylcarbodI ImIde (DCC) (5.92 g, 28.69 
mmol) were added to a solution of 4-benzyIoxybutanoIc 
acid (28) (4.44 g, 22.85 mmol) and 2- 
(trI methyIsI IyI)ethanoI (29) (4.07 g, 34.41 mmol) in 
d I chIoromethane (CH2CI2) (50 ml) at 0°C (Sleber et al., 
1977). The mixture was allowed to stand at 0°C for 48 h. 
Dlcyclohexylurea (DCU) was filtered from the mixture and 
the filtrate was washed with 10% aq NaHC03 (3 x 50 mI), 
water (3 x 50 mI), 10% aq acetic acid (3 x 50 mI), water 
(3 x 50 ml), saturated NaCI (1 x 50 ml), and dried 
of 
Figure 9. Synthetic routes leading to the preparation 
2-(trimethyls!IyI)ethyI-4-hydroxybutanoate (31). 
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(MgSO^ • The solvent was removed to give a yellow 
liquid which was purified by flash chromatography (ethyl 
acetate:SkeI Iy B, 10:90), to afford 30 as a pale yellow 
liquid (6.26 g, 93%) (Figure 9b). 1H NMR (CDCI3, 60 MHz) 
k 0.14 (s, 9H, SiMe3), 0.83 (t, J - 7 Hz, 2H, 2'-CH2), 
1.4-2.0 (m, 2H, 3-CH2), 2.23 (t, J * 6 Hz, 2H, 2-CH2), 
3.32 (t, J - 6 Hz, 2H, 4-CH2), 4.01(t, J = 7 Hz, 2H, 1'- 
CH2), 4.32 (s, 2H, benzyIic-CH2), 7.16 (s, 5H, Ph). IR 
(neat): cm”1 3020 (w, Ph), 1730 (s, COOR) 1250 (m, Si-C) 
700,750 (m, Ph). 
2-(TrImethyI silyI)ethyI-4-hydroxybutanoate (31) 
Palladium on carbon (5%, 300 mg, Aesar, Type II 
unreduced) was added to a cold solution of 30 (3.10 g, 
10.52 mmol) in absolute ethanol (100 ml) In a 500 ml 
hydrogenation flask (Greene, 1981a). The mixture was 
shaken under 2 atm hydrogen for 1.5 h. The catalyst was 
removed by flItration and the solvent was evaporated to 
give 2.11 g (98%) of 31 as a clear liquid (Figure 9c). 1H 
NMR (CDCI3, 60 MHz): k 0.14 (s, 9H, SIMe3), 0.90 (t, J = 
7 Hz» 2H» 2'-CH2), 1.5-2.0 (m, 2H, 3-CH2), 2.25 (t, J = 6 
Hz, 2H, 2-CH2), 3.14 (br s, 1H, OH), 3.50 (t, J = 6 Hz, 
4-CH2),__4.06 (t, J = 7 Hz, 1'-CH2). IR (neat): cm-1 3400 
(br, m, OH), 1730 (s, COOR), 1250 (m, C-SI). 
3,7,i1-TrImethy1-2,6,10-dodecatrlenal (33) 
Farnesol (31) (5.62 g, 25.27 mmol) In CH2CI2 (10 ml) 
was added to a stirred solution of pyrldinium 
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chIorochrornate (PCC) (9.41 g, 43.65 mmol) In CH2CI2 (50 
ml) (Corey and Suggs, 1975). The solution was stirred at 
room temperature for 4 h. Diethyl ether (100 ml) was 
added and the supernatant was decanted from the black 
gum. The Insoluble residue was washed with Et20 (4 x 25 
ml) and the combined washings were passed through a pad 
(3") of Flor Is I I (100-200 mesh), the solvent was removed 
and the residue was purified by flash chromatography 
(ethyl acetate:SkeI Iy B 10:90), to give 33 as a yellow 
oil (4.49 g, 79%) (Figure 10a). 1H NMR (CDCI3, 60 MHz): k 
1.60 (s, 3H, 12-Me), 1.68 (s, 3H, 11-Me), 1.0-2.6 (m, 
14H, allylic H, 3,7-Me), 4.7-5.2 (m, 2H, vinylic 6,10-H), 
5.5-5.7 (m, 1H, vinylic 2-H) 9.7-10.0 (m, 1H, CHO). IR 
(neat): cm”1 2700 (w, a Idehyde C-H), 1675 (s, C«0), 1630 
(w, C=C). The aldehyde was Identified by comparison of 
Its IR spectrum with that of an authentic sample (Sadtler 
No. 1050K). 
3,7,11-TrImethy1-2,6,10-dodecatrlenolc acid (34) 
A saturated aq solution of silver nitrate (6.21 g, 
36.55 mmol) was added with cooling (0-10°C) to a solution 
of farnesal (33) (4.06 g, 18.42 mmol) in ethanol (95%, 30 
^1) (Caliezi and Schinz, 1949). Potassium hydroxide (4.80 
9* 85.54 mmol) In water (200 ml) was added and the 
reaction was stirred at room temperature for 24 h. Silver 
and silver oxide were filtered from the solution, which 
was acidified with 50% H2S04. The mixture was extracted 
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Figure 10. Oxidation and hydrolysis of Juvenile 
analogs, a and b: Two-step oxidation of farnesol 
form its carboxylic acid (34). c: Hydrolysis of 
methoprene (1) using base to form the acid (35). 
hormone 
(32) to 
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into Et20 (4 x 100 ml). The combined extracts were dried 
(MgS04>, the solvent was removed, and the remaining oil 
was purified by flash chromatography (ethyl 
acetate:SkeI Iy B, 25:75) to give 34 as a yellow oil (3.13 
g, 81%) (Figure 10b). 1H NMR (CDCI3, 60 MHz): k 1.60 (s, 
3H, 12-Me), 1.68 (s, 3H, 11-Me), 1.0-2.6 (m, 14H, allylic 
H, 3,7-Me), 4.8-5.2 (m, 2H, vinylic 6,10-H), 5.5-5.7 (m, 
1H, vinylic 2-H), 11.2 (br s, COOH). IR (neat): cm"1 
3500-2500 (m br, COOH), 1690 (s, 0=0), 1640 (m, C=C) , 
1250 (m, C-O). The acid was identified by comparison of 
Its NMR spectrum with that of an authentic sample 
(Sadtler No. 14666). 
2-(TrImethyIsllyI)ethyl 4-(3,7,11-trImethyI-2,6,10- 
dodecatrIenoyIoxy)butanoate (36) 
DMAP (0.039 g, 0.32 mmol) and DCC (0.26 g, 1.26 
mmol) were added to a chilled solution of 34 (0.17 g, 
0.76 mmol) and (3) In CH2CI2 (10 ml). The mixture was 
stirred at 0°C for 5 min and allowed to stand at 0°C for 
24 h. DCU was filtered from the reaction mixture and the 
filtrate was washed with aq NaHC03 (3 x 30 ml), water (3 
x 30 ml), 10% aq acetic acId (3 x 30 mI), dr Ied (MgS04), 
and the solvent was removed. The oily residue was 
Purified by flash chromatography (ethyl acetate:SkeI Iy B, 
10:90), leaving 36 as a pale yellow oil, (0.20 g, 63%) 
(figure 11). 1H NMR (CDC13, 60 MHz): k 0.14 (s, 9H, Me), 
’•54 (S, 3H, 11-Me), 1.0-2.6 (m, 16H, allylic H, 
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Figure 11. Coupling reaction used to synthesize the 
trimethyIsiIyI-esters 36 and 37. 
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SIMe3), 0.84 (t, J - 7 Hz, 2H, 2'-CH2), 1.45 (s, 3H, 12- 
3,7-Me), 3.92 (t, J = 6 Hz, 2H), 4.03, (t, J = 7 Hz, 2H, 
1'-CH2), 4.7-5.1 (m, 2H, vinylic 6,10-H), 5.45 (m, 1H, 
vinlylc 2-H). IR (neat): cm-1 1720-1750 (s, C=0), 1650 
(m, C=C), 1250 (m. Si-C). 
4~*3,7»11“trImethy1-2,6,10-dodecatrlenoyIoxy)butanoic 
acid (38) 
The 2-trImethyIsiIyI ester (36) (0.16 g, 0.38 mmol) 
was slowly added to a solution of tetraethyIammonI urn 
fluoride (Et4F) (0.57 g. 3.78 mmol) In dry acetonitrile 
(CH3CN) (25 ml) and the reaction mixture was heated to 
45°C for 6 h (Carplno and Tsao, 1978). The mixture was 
concentrated and water (25 ml) was added. The ag solution 
was extracted with hexane (1 x 50 ml), acidified with 
H2S04> and extracted with Et20 (4 x 25 ml), dried 
(MgS04), and the solvent was removed. Flash 
chromatography (ethyl acetate:SkeI Iy B:acetlc acid, 
50:50:0.1) gave 38 as an orange-yellow oil (0.10 g, 80%) 
(Figure 12). 1H HMR (CDC13, 60 MHz): k 1.56 (s, 3H, 12- 
Me)’ 1-63 (S’ 3H’ 11-Me). 1.0-2.4 (m, 18H, 3,7-Me ), 4.08 
(t, J - 7 Hz, 2H, 4-CH2), 4.8-5.2 (m, 2H, vinylic 6,10- 
H), 5.5-5.6 (m, 1H, Vinylic 2-H). |R (neat): cm~1 3600- 
2500 (br m, COOH), 1720 (s. C-0), 1650 (m, C=C). 
(2E,4E)-i1-Methoxy-3,7.11-trImethyI-2.4-dodecadIenoIc 
acid (35) 
Methoprene (1) (Isopropyl (2E,4E)-11-methoxy-3,7,1 1 - 
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Figure 12. Deprotection reaction used to remove the 
trimethyisI IyI protecting residue. 
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trimethyI-2,4-dodecadIenoate) (1.09 g, 3.51 mmol) was 
added to 25 ml of a 2.5 M solution of KOH In ethanol 
(Henrick, et al., 1973). The reaction mixture was 
stirred for 18 h, and the solution was concentrated under 
reduced pressure. Water (10 ml) was added, and the 
aqueous solution was extracted with Et20 (2 x 25 ml). 
The aqueous solution was acidified with 50% H2S04, 
extracted with Et20 (3 x 25 ml), and dried (MgS04). The 
solvent was removed leaving an orange residue which was 
purified by flash chromatography (ethyl acetate:SkeI Iy B, 
20:80), to give 35 as a yellow oil (1.04 g, 95%) (Figure 
10c). 1H NMR (CDCI3, 60 MHz): k 0.93 (d, J = 6 Hz, 3H), 
1.11 (s, 6H, 11-Me), 1.2-1.5 (m, 7H, allylic H), 2.0-2.2 
(m, 2H, 6—CH2), 2.29 (s, 3H, 3-Me), 3.13 (s, 3H, OMe), 
5.6-5.7 (m, 1H, vinylic 2-H), 6.2-6.3 (m, 2H, vinylic 
4,5-H), 11.2 (br s, 1H, acidic H). |R (neat): cm’1 3500- 
2500 (s br, COOH), 1690 (s„ C=0), 1610 (s, C=C), 1260 (s, 
C-0). 1H NMR (CDCI3, 60 MHz) (Henrick et al., 1973) : k 
0.88 (d, J = 6 Hz, 3H, 7-Me), 1.13 (s, 6H, 11-Me), 3.18 
(s, 3H, OMe), 5.72 (br, s, 1H, vinylic H-2), 6.13 (m, 2H, 
vinylic 4,5-H). 
2-(TrimethyIsIlyl)ethyl 4-(2E.4E)-11-methoxy-3,7,11- 
trImethyI—2,4—dodecadIenoyIoxy)butanoate (37) 
DMAP (13.4 mg, 0.11 mmol) and DCC (142 mg, 0.69 
mmol) were added to a cold (0°C) solution of 9 and 3 m 
ch2CI2. The solution was stirred for 5 min and allowed 
to stand at o°C for 24 h. DCU was filtered from the 
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solution, which was then washed with 10% aq NaHC03 (3 x 
25ml), water (3 x 25 ml), 10% aq acetic acid (3 x 25 ml), 
water (3 x 25 ml), and saturated aq NaCI (2 x 25 ml), and 
dried (MgS04). The solvent was removed to give a yellow 
residue, which was purified by flash chromatography 
(ethyl acetate:SkeI Iy B 10:90), to give 37 as a pale 
yellow oil (95.5 mg, 66%) (Figure 11). 1H NMR (CDCI3, 60 
MHz): k 0.11 (s, 9H, SIMe3), 0.7-1.0 (m, 5H, 7-Me; 1 ' - 
CH2), 1.12 (s, 6H, 11-Me), 1.2-1.5 (m, 9H, allylic H), 
1.7-2.6 (m, 7H, 3-Me, allylic H), 3.15 (s, OMe), 3.9-4.4 
(m, 4H, 0-CH2), 5.6-5.7 (m, 2H, vinylic H), 6.0-6.2 (m, 
1H, vinylic H). IR (neat): cm”1 1730 (s, 0=0), 1710 (s, 
C*0), 1610 (mC-C), 1250 (m, Si-C). Elemental anayIsIs: 
calculated for C25H4605SI: C, 66.04; H, 10.20. Found: C. 
65.98; H, 9.97. 
4-(2E,4E)-11-Methoxy-3,7,11-trImethy1-2,4- 
dodecadIenoyIoxy) butanoic acid (39) 
The 2-(trImethyIsI IyI)ethyI ester, 37 (0.16 g, 0.33 
mmol), was added to a solution of Et4F (0.61 g, 3.30 
mmol) m dry CH3CN (25 ml), and heated to 45°C for 6 h. 
The reaction mixture was concentrated under reduced 
Pressure and water (25 ml) was added. The aqueous 
solution was washed with hexane (2 x 25 ml) and acidified 
(50% H2S04). The solution was extracted with Et20 (3 x 
25 ml), dried (MgS04) and the solvent was removed, 
having an orange residue. The residue was purified by 
fash chromatography (ethyl acetate:hexane:acetIc acid. 
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50:50:0.1) to give 39 as a yellow oil (79.4 mg, 68%) 
(Figure 12). 1H NMR (CDCI3, 60 MHz): k 0.8 (d, J = 6 Hz, 
3H, 7-Me), 1.12 (s, 6H, 11-Me), 1.3-1.5 (m, 9H, allylic 
H), 1.9-2.1 (m, 4H, 6',3-CH2), 2.2-2.5 (m, 5H, 3'-Me, 1- 
CH2), 3.15 (s, 3H, OMe), 4.15 (t, J = 6 Hz, 2H, 4-CH2), 
5.6-5.7 (m, 1H, vinylic H), 6.0-6.1 (m, 2H, vlnlyic H). 
IR (neat): cm’"1 3500-2500 (m br, COOH) , 1710 (s, C=0) , 
1610 (m, C=C), 1240 (s, C-O), 1150 (s, C-O). Elemental 
analysis: calculated for C20H34O5: C, 67.76; H, 9.67. 
Found: C, 67.60; H, 9.65. 
N-hydroxysuccInlmldyI 4-(2E,4E)-11-methoxy-3,7,11- 
trImethyI-2,4-dodecadIenoyIoxy)butanoate (41) 
DCC (156 mg, 0.75 mmol) was added to a cold (0°C) 
solution of N-hydroxysuccInimIde (40) (54.7 mg, 0.47 
mmol) and 10 (135 mg, 0.38 mmol) in THF (5 ml) (Lauer et 
al.. 1974a; Baehr et al., 1976). The mixture was stirred 
for 5 min and a Mowed to stand at 0°C for 24 h. DCU was 
filtered from the solution and DCC was added (15 ml). 
The organic solution was washed with 1096 aq NaHC03 (3 x 
10 ml), water (3 x 10 ml), 1096 aq acetic acid (3 x 10 
ml), water (3 x 10 ml), dried (MgS04) and the solvent was 
removed. .The yellow residue was taken up In chloroform 
(2 ml), filtered from DCU, and the solvent was removed to 
give Impure 41 an oily solid (134 mg, 7896) (Figure 13a). 
’H NMR (CDCI3- 60 MHz): k 0.8 (d, J - 6 Hz. 3H. 7-Me), 
Figure 13. Formation of activated esters of 
methoprene>spacer (39). a: N-hydroxysuccInImIde (NHS) 
ester (41). b: 1-Hydroxy-2-nItro-4-benzenesuIfonate 
(HNSA) ester (44). 
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1.2 (s, 6H, 11-Me), 2.8 (s, 4H, succinimidyl CH2), 3.15 
(s, 3H, OMe), 4.15 (t, J = 6 Hz, 2H, 4—CH2), 5.6—5.7 (m, 
1H, vinylic H), 6.0-6.1 (m, 2H, vinylic H). IR (neat): 
cm"1 3320 (m, NH, DCU), 1820, 1790, 1740, 1710 (m, m, s, 
s, C=0), 1610 (m, C=C), 1250, 1210, 1160 (m, C=C). 
Sodium 1-Hydroxy-2-nItro-4-benzenesuIfonate (43) 
Sodium 4-hydroxybenzenesuIfonate dihydrate (42) (20 
g, 86.14 mmo!) was added to water (50 ml) at 60°C. 
Nitric acid (12.0 ml, 276.24 mmol) was added dropwise 
over 30 min (King, 1921). The temperature rose to 80°C 
and was maintained for 15 min after addition of the 
nitric acid. The reaction mixture was cooled and orange 
crystals were filtered from the solution. The material 
was recrystallized from ethanoI:water (1:2), to give 43 
as yellow crystals (11.79 g, 5756) (Figure 14). 1H NMR 
<D20, 200 MHZ): * 6.62 (d, J - 10 Hz, 1H, C6-H), 7.31 (d 
Of d, J . 10 Hz, 3Hz, 1H, C5-H), 7.80 (d, J - 3 Hz, 1H, 
C3-H) |R (KBr): cm"1 3460 (s br, OH), 1625 (s, C=C, 
Ar), 1525, 1330 (s, N02), 1200 (s, C-O), 1160, 1050 (s, 
S03), 730-850 (m, 1,2,4-substItuted Ar ring). Elemental 
anaylsls: calculated for C6H4NNaOsS: C, 29.88; H, 1.87; 
N. 5.81; Na, 9.53. Found: C, 29.71; H. 1.58; N, 5.70; Na, 
9-57. According to Klng(1921). the salt was obtained as 
the trihydrate. 
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Figure 14. Preparation of sodium 1 —hydroxy—2 —nitro—4 
benzenesuIfonate. 
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Sod Ium 1-(4-(2E,4E-11-methoxy-3,7,11-trImethy1-2,4- 
dodecadienoyIoxy)butanoyIoxy)-2-n11 ro-4-benzenesuIfonate 
(44) 
Methoprene>spacer (39) (60 mg, 0.17 mmol) was added 
to a solution of 43 In N,N-dImethyIformamIde (DMF) (2 
ml). DCC (60 mg, 0.29 mmol) was added and the solution 
was stirred for 24 h at room temperature (Aldwin and 
Nlteckl, 1987) . DCU was filtered from the solution and 
the filtrate was washed with Et20 (5 ml). The solvent 
was removed under reduced pressure with gentle heating. 
Et20 was added to the orange residue until It solidified. 
Et20 was removed, the solid was taken up In water (3 ml) 
and IyophI I lzed, leaving 44 as a fluffy yellow solid (76 
mg, 77%) (Figure 13b). 
Analysis of Esters of 1—Hydroxy—2—NItro—4—BenzenesuIfon Ic 
Acid (HNSA) 
The amount of material In the form of an ester of 1- 
hydroxy-2-nItro-benzenesuIfonIc acid (HNSA) was 
determined by base hydrolysis of a mixture of the HNSA 
ester and the free dlanlon (46) (Figure 15). 
Methoprene>Spacer-HNSA ester (44) was dissolved In 0.01M 
Phosphate buffer (pH 7.0, 1 ml). The free dlanlon (46) 
was determined by reading the absorbance at 406 nm. a 
second reading was taken after complete hydrolysis of the 
ester with 5N NaOH (50 uL). The difference between the 
two absorbances represents the total amount of HNSA-ester 
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Figure 15. Base hydrolysis of the HNSA ester (44) to form 
methoprene>spacer (39) and the yellow dlanion (46). 
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(Aldwin and Nitecki, 1987). This can be represented as 
A4nfl(NaOH) - AAna x 100 Equation 1. 
a406(Na°H) 
Three sets of absorbance readings were obtained for 
Methoprene>spacer-HNSA ester, giving 29.9% as the 
total amount of ester present in the crude product (Table 
2) . 
3.3. Protein Coupiing Reactions 
Two methods of coupling the derivatlzed methoprene 
molecule to human serum albumin were Investigated. 
—3-1- Coupling of Methoprene>Spacer-N-Hydroxvsucc i n i m I de 
Ester (41) to Human Serum Albumin 
14C-5-Methoprene>spacer-N-hydroxysuccInimIde ester 
(41) (4.17 mg, 9.2 umoI, 2.03 x 104 cpm mg"1) was added 
to a solution of human serum albumin (HSA) (13.15 mg, 
0.19 umol) In THF/H20 (56:44, pH 8.5, 500 uL), and 
stirred for 24 h (Figure 16) (Baehr et al., 1976). The 
solution was transferred to a 4” dialysis tube and 
dialyzed against phosphate buffered saline (0.05M po4-, 
0.05M NaCI, PH 7.4, 1.5 L), and water (1.5 L). Aliquots 
(1 ml) of the dialysis washings were removed, liquid 
scintillation counting medium (8 ml) was added, and the 
aliquots were counted. Dialysis was ended when no more 
radioactivity was detected In the washings. The contents 
of the dialysis tube were lyophlllzed (24 h), giving a 
white fluffy powder (45) (12.87 mg, 4344 cpm mg-1). 
Based on Its radioactivity, the protel 
n product contained 
Table 2. Percentage of Methoprene>spacer-HNSA ester as 
determined by spect rophotomet ry at -406 nm. 
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Amount HNSA-ester 
(ug) a406 A406(NaOH) % ester 
140 
50 
53 
0.500 
0.217 
0.221 
0.714 
0.306 
0.319 
Ave. 
29.97 
29.08 
30.72 
= 29.92 
HNSA: 1-Hydroxy-2-nItro-4-benzenesuIfonate. 
I! 
Figure 16. Formation of the methoprene immunogen (45) 
from the activated NHS-ester (41) and human serum albumin 
(H2N-HSA). 
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21 molecules of methoprene>spacer per molecule of protein 
(see sample calculations. Appendix 2). The reaction was 
repeated twice under similar conditions, but the reaction 
time was increased to 48 h, giving 53 and 48 molecules 
ofmethoprene>spacer per molecule of protein (Table 3). 
3.3.2. Coupling of Methoprene>Spacer-1-Hydroxy-2-NItro-4- 
BenzenesuIfonate (44) to Human Serum Albumin 
14C-5-Methoprene>spacer-1-hydroxy-2- 
nItobenzenesuIfonate (44) (10.52 mg, 18.3 umoI, 
1.5 x 10”4 cpm mg”1) was added to a solution of human 
serum albumin (5.0 mg, 0.072 umoI) in phosphate buffer 
(0.1M P04=, pH 7.0, 500 uL) (Aldwin and Nitecki, 1987). 
The reaction was stirred for 15 min (Figure 17). An 
aliquot of the reaction mixture (10 uL) was added to 
phosphate buffer (i ml). The absorption of this test 
solution was measured at 406 nm to assay the amount of 
liberated HNSA-ester (see section discussion for 
method). Spectrophotometry predicted that 34 residues on 
human serum albumin had reacted with the activated ester 
to form amide bonds (Table 3). 
The reaction mixture was transferred to a 10.5 cm 
dialysis tube and was dlallzed against phosphate buffered 
salIne (1.5 L) and water (1.5 L), until alIquots removed 
(1 ml) contained no radioactivity. The contents of the 
dialysis tube were lyophlllzed (24 h) to give a white 
fluffy solid (45) (4.43 mg). Based on Its radioactivity. 
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Table 3. Comparison of the use of two activated esters 
for the protein coupling reactions used to form the 
methoprene Immunogen, and the quantification of residues 
reacted. 
Ester Trial 
React I on 
T I me 
Res I dues 
14ca 
Reacted 
A406b 
1 24 h 21 NA 
NHS 2 48 h 53 NA 
3 48 h 48 NA 
1 15 min 31 34 
HNSA 2 30 m I n 28 32 
3 180 min 28 27 
^Number of residues reacted was calculated uslnq 
labeled-met hoprene. 
Number of residues reacted was calculated using 
spectrophotometrIc method, where the absorbance 
free dI an ion was measured at A4nR. 
NHS: N-HydroxysuccInimIde. 
5-14C- 
the 
of the 
HNSA: 1-Hydroxy-2-nItro-4-benzenesuIfonate. 
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Figure 17. Formation of the methoprene immunogen (45) 
from the activated HNSA ester (44) and human serum 
albumin. The yellow dianion (46) is liberated by the 
reaction of free lysine groups on the protein with the 
activated ester. 
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the protein was found to contain 31 molecules of 
methoprene>spacer per of molecule protein. This reaction 
was repeated two additional times, with reaction times of 
30 min and 3 h. Based on their radioactivity, the 
protein products contained 28 and 27 molecules of 
methoprene>spacer per molecule of protein, respectively 
(Table 3). 
3.3.3. Competitive Binding Assay of the Methoprene 
Immunogen 
Methoprene>spacer acid (39) (185 ug, 5.2 umoI) was 
added to a solution of the methoprene immunogen (45) (390 
ug, 4.9 nmol, 1500 counts min”1) in phosphate buffered 
saline (500 uL), and stirred for 24 h (Figure 18). The 
solution was transferred to a 10.5 cm dialysis tube and 
was dialyzed against phosphate buffered saline for 24 h. 
Aliquots (1 ml) of the dialysis washing were removed and 
counted. The contents of the dialysis tube were also 
counted. The radioactivity of the dialysis washing was 
not significantly above background. All radioactivity 
was recovered from the contents of the dialysis tube. 
When the same procedure was carried out In the absence of 
the competItor (39) all radloactIvIty was assoc I ated with 
the methoprene Immunogen. 
3.4. Antibody Production 
Eight 8—week—o I d female BALB/c mice were each 
Injected InterperItoneaI Iy with an emulsion of 25-30 ug 
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Figure 18. Competition study of the nature of the radio- 
label on the methoprene immunogen. If the radiolabel was 
in the form of nonspecific binding to the protein, It 
would have been displaced by the excess competitor (39). 
This was not the case. All radiolabel was retained on the 
immunogen. 
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of the methoprene immunogen (45) (53 molecules 
methoprene>spacer per molecule protein) in 50 uL of 
sterilized phosphate buffered saline (0.05M P04=, 0.05M 
NaC I , pH 7.4) and 50 uL of Freund's incomplete adjuvant. 
Booster shots of the immunogen (25-30 ug per mouse) In 
Freund's complete adjuvant (50 uL) and buffer (50 uL) 
were given one month after the Initial injection, and 
again two weeks after the first booster shot. 
Serum from each mouse was collected two weeks after 
the second booster shot. A smaI I length of the mouse 
tall tip (1 mm) from each mouse was cut off and blood (30 
uL) was collected by gentle massaging of the tall. The 
blood was a I lowed to stand at room temperature for 1 h, 
refrigerated (4° C) for 24 h, and centrifuged (10 min, 
5000 rpm). The serum (supernatant, ca 25 uL) was diluted 
twenty times with antibody buffer (TBS-Tween 20: 20 mM 
Tris, 500 mM NaCI, 147 uM BSA, 0.1% thlmerosal, 0.05% 
Tween 20, pH 7.5), and stored under refrIgeratI on. 
The presence of antibodies against the methoprene 
Immunogen (45) was determined by an indirect enzyme 
linked immunosorbant assay (ELISA). Ten immulon 1 PVC 
wells were set up. All wells but well 1 (no antigen 
control) were coated with 10 ug of the methoprene 
Immunogen In carbonate buffer (100 uL, 0.05 M C03=, 0.1% 
thlmerosal, pH 9.6). The wells were Incubated (27°c, 24 
h), and washed (3 x, TBS-Tween 20). All wells were 
Incubated (27°C, 24 h) with BSA blocker solution (200 uL 
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1% BSA-TBS, without Tween 20), and washed (3 x, TBS-Tween 
20). All wells but well 2 (no antibody control) were 
Incubated (27°C, 24 h) with the mouse antisera (100 uL, 
diluted 1:20 with antibody buffer). Individual wells 3 
through 10 corresponded to serum collected from 
Individual mice numbered 1 through 8. The wells were 
washed (3 x, TBS, without Tween 20). Goat antimouse 
horseradish peroxidase conjugated antibody (100 uL, 
diluted 1:300 with antibody buffer) was added to all 
wells and Incubated (27°C, 5h). The wells were washed 
(3x, TBS-Tween 20) and substrate solution (100 uL, 0.16 M 
sod I urn acetate, 0.05 M NaH2P04, 0.12 M H202, 20 mM ABTS, 
0.01% thimerosaI) was added to each well. The wells were 
incubated (27°C, 15 min) and their absorbances (O.D.) 
were recorded at 410 nm. 
Chapter 4. 
ResuIts 
4.1. Synthesis of the Four Carbon Spacer Group 
© 
The synthesis of the protected four carbon spacer 
group (31) began with the reaction between benzyl alcohol 
(25) and sodium to form sod Ium benzyloxide (26). The 
addition of 4-butyrolactone (27), with heating, formed 
4-benzyIoxybutanoIc acid (28) (Figure 9a) (Sudo et al., 
1967). The benzylether of 28 served as a protecting 
group In the four-position. The overall yield of the 
reaction was poor (21%). No other byproducts from the 
reaction were isolated. 
The next step required the protection of the 
carboxylic acid group of 28 (see discussion section 
5.3.2., p. 114). This was accomplished by the reaction 
of 28 with 2-(tr1methyIs1 1yI)ethano1 (29) using the 
coupling reagent, 1,3-dieye Iohexy1 carbodi imide (DCC), and 
the amine, 4-(N,N-dimethy1)amino pryidine (DMAP) (Sieber 
et al., 1977) (Figure 9b). The formation of the 
trimethyisilyl ester (30) resulted, along with the 
byproduct, 1,3-dieye 1ohexy1 urea. The urea precipitated 
from the reaction solution and the majority of it was 
removed by filtration. Traces of the urea, however, were 
always present in the product. The most efficient way of 
removing the urea was by flash column chromatography 
(Still et a I ., 1978). 
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The protected ester (30) underwent Its first 
deprotection step by catalytic hydrogenation (Greene, 
1981a). The benzylether (30) was cleaved exclusively 
between the benzyl group and the oxygen to form the 
alcohol 31 (Figure 9c). Unreduced, Aesar type II, 
palladium catalyst gave the best yield (98%) over the 
shortest period of time (1.5 h) with 2 atm H2. 
2-(TrimethyIsI IyI)ethyI-4-hydroxybutanoate (31) was then 
coupled to the carboxylIc acids of two Juvenlle hormone 
analogs, farnesol (32) and methoprene (1), forming 
dI esters. 
4.2. Formation of Carboxylic Acids of Two 
Juvenile Hormone Analogs 
The Juvenile hormone analog, farnesol (32), had to 
be oxidized to Its carboxylic acid in a two step 
procedure. The alcohol (32) was treated with pyrldlnium 
chlorochromate (Corey and Suggs, 1975) to form the 
aldehyde (33) (Figure 10a). This reagent has been used 
as a general oxidizer of primary and secondary alcohols 
to their respective aldehydes. Oxidation of 33 with 
silver nitrate and potassium hydroxide in aqueous ethanol 
(Caliezi and Schinz, 1949) gave the carboxylic acid (34) 
(Figure 10b), along with metallic silver which was 
filtered from solution. Both the aldehyde (33) and the 
acid (34) were in the form of yellow oils which were 
purified by flash column chromatography. 
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Methoprene (1) was hydrolysed to Its acid (35) by 
treatment with potassium hydroxide In ethanol (Henrlck et 
al., 1973) (Figure 10c). It, too, was In the form of a 
yellow oil and was purified by column chromatography. 
4.3. Coupling of the Four Carbon Spacer Group 
to Juvenile Hormone Analogs 
2-(TrImethyIsI IyI)ethyI-4-hydroxy butanoate (31) was 
coupled to the carboxylic acids 34 and 35 to form the 
protected dlesters 36 and 37, respectively (Figure 11). 
The coupling reagent used was DCC. Purification of these 
esters was by flash chromatography. 
The protected trImethyIsI IyI esters 36 and 37 were 
deprotected using tetraethyIammonI urn fluoride (Et4F) 
(Sleber et al.,1977; Carplno et al., 1978) (Figure 12). 
This reagent selectively deprotected the esters to form 
the carboxyllc acids 38 and 39, without attacking other 
functional groups. 
4.4. Preparation of Activated Esters of 
Methoprene>Spacer (39) 
The carboxylic acid function generated by the above 
deprotection step enabled the further reaction of the 
methoprene homo Iog (39, methoprene>spacer) with alcohols 
to form activated esters. It should be noted that 5-14c- 
methoprene was added to unlabeled methoprene prior to its 
hydrolysis and subsequent derI vat IzatI on to 39. The 14C- 
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label acted as a tracer during the preparation of the 
methoprene Immunogen (45). Two methods of preparing 
activated esters of methoprene>spacer (39) were employed 
(FIgure 13). 
The first method followed the procedures reported by 
Lauer et al. (1974a) and Baehr et al. (1976) for the 
preparation of an activated N-hydroxysuccInImIde ester of 
Juvenile hormone (19, Figure 7b). 14c-5- 
Methoprene>spacer was coupled to N-hydroxysuccInImIde 
with DCC Figure 13a). The resulting activated ester 41 
was Isolated In an Impure form, with DCU as the 
contaminant (IR 3320, m, NH). The ester was used, 
without further purification, in protein coupling 
react Ions. 
A water soluble activated ester of 39 was also 
prepared by the method of Alwln and Nltecki (1987) 
(Figure 13b). The reagent, 1-hydroxy-2-nItro-4- 
benzenesuIfon Ic acid (43) was formed by the method of 
King (1921). Sod Ium 4-hydroxybenzenesuIfonate, dihydrate 
(42) was nitrated In water with an excess of nitric acid 
to form 43 (Figure 14). The elemental anaylsis reported 
by King for the trihydrate, C6H4NNa06S•3H20, found H20: 
18.7, Na:9.55 per cent. When the reaction was repeated 
and the product was thoroughly dried, the analysis gave, 
for the unhydrated acid (43), C6H4NNaOeS: required C: 
29.88, H: 1.67, N: 5.81, Na: 9.53; found C: 29.71, H: 
1*58, N: 5.70, Na:9.57. Spectral data (Appendix 1, 
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Figures A-23 and A-24) confirmed the structure of the 
material as unhydrated, 1-hydroxy-2-nItro-4- 
benzenesuIfonic acid. it is unclear as to why there is a 
discrepancy between the literature analysis and the 
analysis reported here. It is clear, however, that the 
theoretical content of sodium for the trihydrate should 
be 7.79 per cent, not 9.55 per cent, which corresponds to 
the sodium content of unhydrated material (43). 
Once the structure of 43 was confirmed, it was 
reacted with 14C-5-methoprene>spacer (39) using DCC in 
DMF at room temperature (Figure 13b) (previous DCC 
couplings were carried out at 0°C) . The activated ester 
(44) was also isolated In an Impure form; however. It was 
very water soluble. This is the first report of a water 
soluble derivative of methoprene (1). 
4.5. Immunogen Preparation 
As previously stated, methoprene must be conjugated 
to a large molecule to elicit an Immune response In 
mammals. The formation of two activated esters of 
methoprene enabled the comparison of two protein 
conjugation reactions. 
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4.5.1. The N-HydroxysuccIn1mide Ester Method 
The formation of an Immunogen for Juvenile hormone 
using the activated N-hydroxysuccInImIde ester of the 
hormone (Lauer et al., 1974a; Baehr et al., 1976) (Figure 
7) served as a model for the coupling of 
methoprene>spacer-N-hydroxysuccInImIde ester (41) to the 
protein, human serum albumin. The protein was first 
dissolved In a THF/H20 solution (50:50, pH 8.5). 
Methoprene>spacer-N-hydroxysuccInImIde ester (41) was 
added and the final THF/H20 concentration was adjusted by 
the addition of small amounts of THF (Figure 15). This 
Is in contrast to previously reported juvenile hormone 
protein coupling reactions, where the pH was 9.5 and the 
solution favors the solubllty of the protein (Baehr et 
al., 1976). Hydrolysis of activated N-hydroxysuccInImide 
esters Is encouraged at higher pH's (unreported results). 
To reduce hydrolysis of the methoprene>spacer-N- 
hydroxysuccInImIde ester, the pH of the reaction was 
Iowered. 
A reaction time of 48 hours seemed to allow for the 
reaction of many of the available amine residues on the 
protein (Table 3). Human serum albumin has 99 basic 
amino acids, 59 of those are lysine; 24 are arginine; and 
16 are histidine (Meloun et al., 1975; Walker, 1976; 
Dayhoff, 1978). Of the uncharged and nonpolar amino acids 
on human serum albumin, 18 are tyrosine, and one Is 
tryptophan. All of these amino acids may contribute to 
the conjugation of methoprene>spacer to the protein 
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however, it has been shown that lysine is involved in 
conjugation reactions more often than the other amino 
acids (Jacobsen et al., 1972). Because no attempt was 
made to determine which amine residues reacted with the 
activated esters, the number of potential residues which 
could react was assumed to be 99. 
The use of ^C-5—methoprene enabled the quantitative 
measurement of the number of amine residues reacted by 
direct liquid scintillation counting of the protein 
product. A maximum of 53 amine residues on one molecule 
of human serum albumin reacted with 41 to form the 
methoprene Immunogen (45). The number of residues taken 
up In this reaction is greater than for previous reports 
for Juvenile hormone Immunogen preparation (Table 4). 
The radiolabeled methoprene>spacer hapten (39) was not 
competitively removed from the immunogen (45) by an 
excess of unlabeled methoprene>spacer (39), signifying 
the hapten was covalently bound to the protein (Figure 
18) . 
— -2- The 1-Hydroxy-2-N ijt ro-4-Benzenesu I fonate Ester 
Method 
The second method of conjugating methoprene>spacer 
(39) to a protein used the water solubl 
e activated HNSA- 
Table 4. Comparison of the number of haptens per molecule 
of protein for Juvenile hormone and methoprene Immunogen 
preparatIons. 
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Hapten #Haptens/Prote1n 
Method of Immunogen 
PreparatI on 
JH 1 26a NHS Activated Ester 
JH 1 Diol 17b Carbodl imide Coup 1 Ing 
JH 1 1 1 20c NHS Activated Ester 
JH III Diol 20d NHS Activated Ester 
Methoprene 53e NHS Activated Ester 
Methoprene 3 1 e HNSA Activated Ester 
aBaehr et a I . , 1976 . 
bStrambI et a I., 1981. 
bLauer et a I., 1974a. 
aBaehr et a I., 1987. 
eMeI, 1988, this report. 
NHS: N-hydroxysuccinlmlde. 
HNSA: 1-Hydroxy-2-nItro-4-benzenesufonate. 
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ester (44). This ester was extremely water soluble 
despite the hydrophobic nature of methoprene. This was 
advantageous since the concern over solubilizing the 
reactants was eliminated (Aldwin and Niteckl, 1987). 
Both the activated ester (44) and human serum 
albumin were soluble in phosphate buffer at pH 7.0 
(Figure 17). The reaction time for this method was much 
faster than that of the N-hydroxysuccInimIde ester method 
(30 min vs. 48 h). Again, the use of 14C~methoprene 
allowed for direct quantification of the number of amine 
residues on the protein which had reacted with 44. in 
this case, 28 residues on human serum albumin had reacted 
with the activated ester after 30 min (Tables 3 and 5). 
4_.5.3. Assay of Methoprene>Spacer-HNSA Ester Protein 
Coupling Reaction 
The 1-hydroxy-2-nItro-4-benzenesu1fonate ester 
method also has the advantage of being monitorable by 
spectrophotometry. A yellow dianion (46) is formed when 
the activated ester 44 reacts with nucleophiles (base or 
free amine groups on a protein) (Figures 15 and 17). 
When the methoprene>spacer-HNSA ester (44) and human 
serum albumin were allowed to react, the free HNSA 
dlanion (46) was liberated. The dlanion absorbs light in 
the visible region at 406 nm, and was detected by 
spectrophotometry. As the reaction proceeded, the 
absorption of the dlanion Increased. When the 
spectrophotometrIc readings at A406 were corrected for 
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the free dianion, 1-hydroxy—2-nItro—4—benzenesuIfonate, 
the number of amine residues reacted were directly 
related to the amount of liberated dlanlon (Table 5). 
When values obtained from the spectrophotometrIc 
method were compared with those obtained from the 
covalently bound radiolabeled methoprene>spacer (39), the 
two methods agreed with the number of methoprene 
molecules bound per molecule of protein (Tables 3 and 5). 
AIdwIn and Nlteckl (1987) monitored the reaction of their 
HNSA ester with a protein by spectrophotometry alone, and 
did not offer a comparison with a radiolabeled tracer. 
4.6. Preliminary Production of Antibodies 
Against the Methoprene Immunogen 
The immunization schedule employed showed the 
presence of antibodies In mice eight weeks after the 
first Injection of the methoprene Immunogen (46). The 
introduction of the Immunogen Into the mice caused each 
mouse to mount an Immune response. Antibodies against 
the Immunogen were secreted Into the blood stream. 
Serum, rich in antibodies, was collected from each mouse 
by removal of the blood cells by centrifugation (Figure 
19) . 
Using the Indirect ELISA method for antibody 
detection (Figure 20), antibodies against the methoprene 
Immunogen were seen In mouse sera which had been diluted 
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Table 5. The spectrophotometrIc method of calculating the 
number of methoprene molecules conjugated per molecule of 
protein. A comparison of the two methods shows that they 
are in agreement. 
React I on 
T I me 
(min) 
Crude 
Ester 
(mg) 
Dlanion 
Start 
(umo1) A0 At 
A 
Res I dues 
Reacted 
(Method) 
. _ _ a 14rb 
406 u 
15 10.52 21.86 0.750 0.837 34 31 
30 8.11 16.86 0.579 0.640 32 28 
180 8.50 17.66 0.607 0.656 27 28 
The spectrophotometrIc method required two readings at 
406 nm; Aq determined the amount of free dlanion in the 
sample at time ■ 0 min; At determined the amount of 
dlanion liberated by the reaction of the HNSA-ester with 
groteln at the end of a reaction time. 
C-methoprene was used to determine the number of 
methoprene molecules conjugated per molecule protein. 
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Figure 19. 
mice caused 
spec IfIc to 
portion of 
Injection of the methoprene immunogen Into 
an immune response to be mounted. Antibodies 
the immunogen were collected In the serum 
the blood. 
Immunogen o-o 
Inject 
V 
™ rth rfri 
Mouse 
Antibodies 
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Figure 20. The indirect enzyme linked immunosorbent assay 
(ELISA). (From Detoma and MacDonald, 1987). 
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1:20. Based on the optical density readings after only 
15 min of incubation of the goat antimouse horseradish 
peroxidase conjugated antibody with substrate. It seemed 
that the titer and specificity of the mouse antibodies 
raised against the methoprene immunogen was high. All 
eight mice showed the presence of antibodies, with three 
mice giving a very positive response (Table 6, # 6, 7, 
8) . 
Table 6. Optical Density (O.D.41Q) of mouse serum 
produced against the methoprene immunogen after 15 min 
incubation using the ELISA method of analysis. 
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Mouse serum # Recording 1 Record Ing 2 
Antigen control B 1 ank B 1 ank 
Antibody control 0.002 0.006 
1 0.448 0.477 
2 0.459 0.559 
3 0.392 0.421 
4 0.549 0.694 
5 0.519 0.656 
6 0.921 1.134 
7 1.242 1.189 
8 0.921 0.935 
Chapter 5. 
Discussion 
5.1. Choice of a Carrier Molecule for Methoprene 
The structure of the methoprene immunogen (45) was 
designed to produce antibodies specific to the methoprene 
molecule. The production of specific antibodies against 
methoprene is dependent on an animal system for which there 
is only limited control. The immunogen structure, 
therefore, had to meet a number of requirements to give it 
the greatest chance of producing antibodies In mice. These 
requirements were: a) that the methoprene molecule be 
presented to the animal in Its native form; b) that the 
carrier molecule for methoprene be large enough to be seen 
as a foreign entity; c) that the carrier molecule have many 
sites for covalent attachment of methoprene; and d) that the 
concentration of methoprene on the carrier molecule be high 
enough to present many molecules of methoprene to the 
animal's immune system. 
Due to Its smaI I size, methoprene (molecular weight 310 
g/mol) does not cause an immnune response. Generally, 
molecules of greater than molecular weight 10,000 are used 
as antigens. Methoprene, therefore, had to be covalently 
attached to a large carrier molecule in order to meet the 
above requIrements. The carrier molecule used was the 
Protein human serum albumin (molecular weight 69,000, Merck 
1 nc*ex, 1976). 
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Human serum albumin was chosen for a number of reasons. 
It was used successfully as a carrier molecule for juvenile 
hormone Into rabbits (Lauer et al., 1974a; Baehr et al., 
1976; Strambl et al., 1981). It has a maximum of 99 free 
amine residues aval table for the covalent attachment of 
methoprene (Jacobsen et al., 1972; Meloun et al., 1975; 
Walker, 1976; Dayhoff, 1978). Lysine has been found to be 
of major Importance to the immunoreactIvIty of human serum 
albumin (Jacobsen et al., 1972). There is still no 
consensus on the optimum number of haptens needed to obtain 
high antibody titer and specificity. Therefore, no effort 
was made to Iimit the number of methoprene molecules 
covalently bound to the protein. Human serum albumin has 
also been known to remain very soluble In aqeous solution 
when heavIly loaded with haptens. 
5.2. The Per I vat IzatIon of Methoprene 
The conjugation of methoprene to human serum albumin 
required that a reactive functionality on methoprene be 
formed prior to Its reaction with free amine groups on the 
protein. Methoprene (1) has two places where reactive 
functionalities may be formed, at either the methoxy end or 
at the carboxyl end. The place of conjugation to the 
Protein would greatly affect the nature of the antibodies 
raised against the resulting immunogen. 
The methoxy moiety at carbon 11 could have been 
replaced with a hydroxyl function, followed by further 
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reaction with, perhaps succinic anhydride, to form a 
carboxylic acid which could then be coupled to the protein 
with a coup I Ing reagent. This approach, however, would 
change the configuration around carbon 11 such that 
antibodies against the Immunogen would no longer recognize 
11-methoxy-methoprene, but would recognize 11-hydroxy- 
methoprene. Such was the case with the Juvenlle hormone 
radioimmunoassay for Juvenile hormone dlol (7) (Strambi et 
al., 1981). The juvenile hormone epoxide function between 
carbons 10 and 11 was hydrolyzed to form the dlol (7), 
followed by coupling to the protein via a hem IsuccInate 
derivative (22) (Figure 8). The resulting antibodies only 
recognized Juvenile hormone dlols, without distinguishing 
between the dlol homo logs (Table 1). This approach was not 
chosen for methoprene since antibodies against such an 
Immunogen would most likely not recognize methoprene In Its 
natIve form. 
The alternative, then, relied on the derI vat IzatI on of 
methoprene at Its carboxyl end. The simplest way to form a 
reactive moiety on methoprene used base hydrolysis of the 
isopropyl ester at carbon 1 to form the carboxylic acid 
(35). This acid could have been conjugated to human serum 
albumin directly by a coupling reagent, or an activated 
ester of the acid could have been formed with 
N-hydroxysuccInlmlde. This approach was taken for Juvenile 
hormone by both Lauer et al. (1974a) and Baehr et al. (1976, 
1981 > * The resulting antibodies recognized Juvenile hormone 
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acids and cross reacted significantly with other Juvenile 
hormone homo logs (Table 1). 
This route was not chosen for methoprene, primari ly 
because It was not desired to have antibodies recognizing 
methoprene acid (35). The form of methoprene which results 
In the greatest disruption of the life cycles of Insects Is 
the isopropyl ester (1). An immunoassay for methoprene 
should detect it In its most active form, the ester, to give 
field applicators accurate Information on its presence and 
ability to continue to control Insects in the environment. 
It was therefore decided that the best way to obtain 
antibodies against methoprene for subsequent immunoassays 
was to raise antibodies which would recognize the ester (1). 
This was accomplished by forming, from methoprene acid (35), 
a derivative which contained an ester function to mimic 
native methoprene, and a carboxylic acid function for 
coupling to the protein carrier. The resulting material, 
methoprene>spacer (39) was then coupled to human serum 
a I bum In. 
5.3. The Four Carbon Spacer Group 
The synthesis of methoprene>spacer (39) required 
special consideration. For both an ester function and a 
terminal carboxylic acid function to be Incorporated Into 
39. the addition of a hydroxy-carboxylic acid was necessary 
The material chosen for this addition was 4-hydroxybutanoIc 
ac1d (47) (FIgure 21). 
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Figure 21. If left unprotected, 
can eye I Ize with itself to form 
4-hydroxybutano Ic acid (47) 
the 4-butyrolactone (27). 
1 12 
12 -Hz0 
acid catalyzed 21 
1 13 
The decision to use 4-hydroxybutanoic acid was based on 
a number of factors. The antibodies raised against an 
immunogen prepared from juvenile hormone acid had greater 
affinities for the acid over the native hormone (Lauer et 
e 
al., 1974a; Baehr et al., 1976). Based on these results, it 
was hoped that the addition of an ester function to 
methoprene acid (35), via a spacer group, would enhance the 
chance of the subsequent immunogen to raise antibodies 
against native methoprene (1). 
5.3.1. Effect of Spacer length 
The Importance of placing a spacer group between a 
hapten and Its carrier has been shown in studies of 
immunogenicity of haptens bound to liposomes. Liposomal 
immunogen IcIty was dependent on an optimal distance 
separating the hapten from Its hydrophobic anchor within the 
liposome bllayer (Klnsky et al., 1984). Liposomes which 
contained no spacer or contained a twelve carbon spacer were 
non-Immunogen Ic, In contrast to the maximum Immune response 
Induced by liposomes containing a six carbon spacer. A 
similar result was found for hapten bound to avldln, a basic 
glycoprotein of moledular weight 16,000 (Scott et al., 
1984). Hapten-avid In complexes lacking a six carbon spacer 
group failed to Induce an antibody response. Spacer length 
has also been shown to affect the ability of I gG antibodies 
to bind to liposome surfaces containing am InoethyIthIoacety I 
(AETA) spacers (spacer length of four atoms) (Hashlmoto et 
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al.» 1986). Liposomes containing no AETA spacer did not 
bind IgG antibodies, in contrast to the significantly higher 
I gG attachment by liposomes containing one AETA spacer (four 
atoms) or two AETA spacers (eight atoms). Additionally, 
these four to eight atom spacer groups, which may contain 
carbon, nitrogen, or sulfur atoms, do not induce an Immune 
response (Aldwin and Nltecki, 1987; Hashimoto et al., 1986). 
Such "featureless" structures confer length and flexibility 
to Immunogen structure. 
A four carbon spacer group was placed between 
methoprene and Its carrier. It is cone IevabIe that this 
provided the necessary length to place methoprene above the 
surface of the protein. It is also conceivable that a 
spacer length of six or eight carbons may further enhance 
the Immune response against the methoprene Immunogen. A 
study of the effects of spacer length Is, however, beyond 
the scope of this thesis. 
—• 3‘2 :_Protection of the Four Carbon Spacer Group 
The spacer group, 4-hydroxybutanoIc acid (47), is a 
bifunctional material which has a tendency to lose a mole of 
water under acidic conditions, resulting in formation of the 
cyclic product, 4-butryoIactone (27) (Figure 21). The 
reaction required to couple 4-hydroxybutanoIc acid (47) to 
methoprene acid (36) used the reagent 1,3- 
dI eye IohexyIcarbodIImIde (DCC). This reagent acts, i n both 
the coupling reaction and the cycllzatlon process. as a 
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dehydrating agent and since a 5-membered ring is formed in 
the latter case, ring formation is likely to be predominant. 
In fact, preliminary experiments which attempted to couple 
farnesoic acid (34) with 4-hydroxybutanoic acid, using DCC, 
yielded the lactone. 
The necessity of protecting 4-hydroxybutanoIc acid 
became apparent very quickly. A sequence of protection- 
deprotection reactions were carried out to prevent the 
formation of the lactone (27). The preparation of 
4-benzyloxybutanoic acid (28) protected the hydroxyl 
function at 4-C of 4-hydroxybutanoIc acid (47) with a 
benzylether. This allowed for the independent protection of 
the carboxylic acid function at 1-C. 
The choice of a protecting group for the carboxylic 
acid was of some concern, primarily because the protecting 
group would have to be removed as the last step to generate 
methoprene>spacer (39). The reagent used to remove the 
protecting group would have to be extremely selective in 
that it could not attack any of the functionalities in 
methoprene (1), namely the methoxy function at 11-C, the 
conjugated double bonds between 2-C and 4-C, and the ester 
function at 1-C. 
Because of these restrictions, the protecting group 
chosen was the (2-trimethyIsI IyI)ethyI residue. This 
residue has been used as an N-protecting group which was 
found to be selectively cleavable with fluoride Ion under 
m 1 1 dIy basic conditions (Carplno and Tsao, 1978). This 
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residue was also applied as a carboxylic acid protecting 
group with cleavage under the same mild conditions. 2- 
(TrimethyIsI IyI)ethyI esters prepared from 2- 
(trimethyIsI IyI)ethanoI (29) and the carboxylic acid 
residues of peptides were stable under workup conditions and 
during hydrogenation (Sleber et al., 1977). The mild 
cleavage conditions and the stab! I Ity of these esters made 
this protecting group the most attractive. There are many 
protecting groups available for carboxylic acid protection 
(Greene, 1981b), but their removal requires hydrogenation, 
or more acidic or alkaline conditions which may attack the 
methoprene molecule. 
The preparation of the trimethyIsI IyIethyI ester (30) 
from 4-benzyIoxybutanoIc acid (28) and 2- 
(trImethyIsilyI)ethanol (29), gave a protected four carbon 
spacer group which could not yield the lactone (Figure 9b). 
The next step required the removal of the benzyl ether 
protecting the hydroxyl group of 2-(tr imethyIsIIyI)ethyI-4- 
benzyloxybutanoate (30). This was done with catalytic 
hydrogenation to give the protected derivative, 2- 
(trImethy1sI IyI)ethy1-4-hydroxybutanoate (31) (Figure 9c). 
This deprotection step generated the free hydroxyl group 
needed to continue the synthesis of methoprene>spacer (39). 
A general carbodl imlde coup I Ing reaction was used to 
Prepare protected (trImethyIsI IyI)ethyI esters of the 
carboxylic acids of both farnesol (34) and methoprene (36) 
(Figure 11). Products of this reaction (36 and 37) 
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contained an ester function on either end of the parent 
compound, 4-hydroxybutanoIc acid (47). The ester function 
at 1-C was part of the 2-(trImethyIsiIyI)ethyI carboxylic 
acid protecting residue. As stated above, this residue is 
sensitive to attack with fluoride ion. The deprotection 
reaction to remove the residue was carried out in the 
presence of tetraethyIammoniurn fluoride as the source of 
fluoride ion (Figure 12). The carboxylic acids generated 
contained the parent molecule, 4-hydroxybutanoic acid (47), 
and a Juvneiie hormone analog, either farnesol or 
methoprene, covalently bound by an ester function. 
5.4. The Use of Activated Esters In the 
Preparation of the Methoprene Immunogen 
Two of the most commonly used methods of coupling 
haptens to proteins are the use of activated ester 
derivatives of the haptens, and the use of coupling reagents 
such as carbodiimIdes. Water soluble carbodiimIdes such as 
1 -eye IohexyI-3-(2-morphoIInyI-4-ethyI) carbodllmlde methyl 
P-toluene sulfonate (CMC) or 1-ethyI-3-(3- 
dimethyI ami nopropyl) carbodllmlde (EDC) have been used to 
directly couple water soluble carboxylic acids with proteins 
(Hammock and Mumma, 1980; Strambl et al., 1981). These 
cabodiimldes, however, have the tendancy to cross link 
Proteins, greatly reducing the solubility of the Immunogen. 
The first attempts at conjugating methoprene>spacer 
(39) to human serum albumin used EDC as the coupling 
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reagent. The resulting protein product contained only a 
trace amount of 14C-labeled methoprene, and was highly 
insoluble In neutral buffer solutions (unreported results). 
It was concluded that the lack of solubility of the 
methoprene derivative (39) under the aqueous, acidic 
conditions necessary for an EDC coupling resulted in the 
cross linking of the protein. This method has been used to 
conjugate a water soluble Juvenile hormone diol derivative 
to human serum albumin (Strambl et al.f 1981); however, EDC 
can not be used when the reactants are not soluble under the 
appropriate reaction conditions. 
Alternatively, activated ester derivatives provide good 
leaving groups In the presence of nucleophiles. Immunogen 
prepartlon techniques have frequently used activated ester 
derivatives to couple haptens to nucleophilic determinants 
on proteins. Carboxylic acid derivatives of N- 
hydroxysuccInImIde have been frequently used as activated 
esters for protein conjugation. This method of conjugation 
to proteins has been used for derivatives of pesticides such 
as allethrln and dIfIubenzuron (Hammock and Mumma, 1980), 
and Insect hormones such as Juvenile hormone (Lauer et al., 
1974a; Baehr et al., 1976) and ecdysone (Lauer et al., 
1974b) . 
5^4-1. The N-HydroxysuccInImIde Ester Method 
The failure of the direct carbodiimide coupling of 
methoprene>spacer to human serum albumin prompted the 
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preparation of the N-hydroxysuccinImide derivative of 
methoprene>spacer (41) (Figure 13a). The successful use of 
such derivatives had already been demonstrated for Juvenile 
hormone immunogen preparations (Lauer et al., 1974a; Baehr 
et al., 1976). However, the pH used for these react ions was 
very alkaline (pH 9.5). N-hydroxysuccinimIde esters have 
been shown to be stable under acidic conditions, but are 
sensitive to base hydrolysis; they are also fairly Insoluble 
In aqueous solutions. To be able to solubilize both the 
ester and the protein. It was necessary to use a mixture of 
THF:H20 (1:1) and high pH (9.5). Protein solubility was 
greatly increased at this alkalIne pH in the presence of an 
organic solvent. These conditions, however, would have 
caused the hydrolysis of the ester before It could react 
with amines on the protein, resulting In Juvenile hormone 
Immunogens with between 17 and 26 of the available amines 
reacted (Table 4), as reported by the above mentioned 
authors. 
Prior to repeating this procedure for the preparation 
of the methoprene Immunogen (45), an N-hydroxysuccInImIde 
ester of a related compound, llnolelc acid, was prepared. 
This ester was placed In a number of solutions of THF:H20 
('•I) with varying pH, as a means of testing the effect of- 
PH on N-hydroxysuccInlmIde esters. The ester was quickly 
hydrolysed in pH 9 and above, but that the rate of 
hydrolysis was far slower If the pH was adjusted to below 9 
(personal observations). 
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To obtain the greatest reaction between the N- 
hydroxysuccinimide ester of methoprene>spacer (41) and human 
serum albumin, the reaction conditions were modified so that 
the pH was lowered to pH 8-8.5, and the concentration of 
THF:H20 was slightly greater for THF (1.3:1, v/v) (Figure 
16). Over a reaction time of 48 h, a protein conjugate was 
formed with 53 molecules of hapten per molecule of protein. 
This Immunogen contained more haptens than any previously 
reported Immunogens for either the activated ester methods 
or the carbodllmlde coupling ractlon (Table 4). 
5.4.2. The 1-Hydroxy-2-NItro-4-BenzenesuIfonate Ester Method 
The N-hydroxysuccInimIde ester coupling method worked 
Quite well for preparation of the methoprene Immunogen (45) . 
When It was found, however, that a water soluble activated 
ester of methoprene could be prepared (Aldwin and Nlteckl, 
1987), this route was also pursued. The idea of a water 
soluble activated ester was very appealing since it would 
allow the reaction between the ester and the protein to 
occur in an aqueous medium. 
The preparation of a water soluble active ester of 
methoprene first required the synthesis of sod I urn 1-hydroxy- 
2-nitro-4-benzenesuIfonic acid (43) (HNSA). This was 
accomplished easily by the nitration of sod I urn 4- 
hydroxybenzenesuIfonate dI hydrate (42) (King, 1921) (Figure 
14)* The resulting phenol (43) was water soluble. The 
activated ester of methoprene>spacer (39) was prepared using 
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a DCC coupling reaction (Figure 13b). This derivative of 
methoprene (44) readily dissolved into aqueous solutions. 
Esters prepared from 1-hydroxy-2-nitro-4-benzesuIfonate 
absorb below 300 nm (Aldwin and Nltecki, 1987). Hydrolysis 
of the activated ester (44) by base resulted in the 
formation of the parent acid, methoprene>spacer (39), and 
the dianion (46) (Figures 15). The ability to detect the 
free yellow dianlon (46) with spectrophotometry (406 nm) 
provided a means to calculate the amount of ester formed 
from the DCC coupling reaction, without further purification 
of the product. The relation expressed In equation 1 (page 
74) was used to calculate the total amount of material 
present as the ester 44. 
The formation of the methoprene Immunogen (45) was the 
result of the reaction between the 1 —hydroxy—2—n11ro-4— 
benzenesuIfonate ester of methoprene (44) and human serum 
albumin. The generation of the yellow dianlon In the 
presence of nucleophiles (free amine groups on human serum 
albumin) also allowed for its measurement (Figure 17). The 
number of amine residues on human serum albumin which had 
reacted with the activated ester (44) was calculated based 
on the relationship between the amount of free dianlon 
present at the start of the reaction and the amount of free 
dianlon that was liberated at the end of the reaction 
(Appendix C, page 190). Both methods, direct scintillation 
counting of the radiolabeled immunogen (45) and 
spectrophotometrIc measurement of the liberated dianlon 
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(46), compared well with each other (Tables 3 and 5). The 
rapid progress of the HNSA reaction seemed to a I low for 27- 
34 residues on one molecule of protein to react with the 
activated ester (Table 5). 
The correlation between the two methods for determining 
the number of haptens covalently bound to the protein 
provides an alternative to the use of a radlolabled 
derivative. The spectrophotometrIc method was useful In 
that It provided an accurate view of the rate of the 
reaction over a short period of time. Scintillation 
counting of the labeled protein product, however, provided a 
direct means of obtaining the ultimate result. 
The ability to synthesize water soluble activated 
esters of Juvenile hormone analogs also has many advantages. 
For many years research has been hampered by the 
hydrophobIcIty of Juvenile hormone and many of Its analogs, 
methoprene Included (Glese, 1977; Granger, 1982). Now, for 
the first time. Juvenile hormone analog derivatives may be 
completely solubilized In aqueous solutions. Conjugation of 
such derivatives to hydrophilic materials such as proteins 
or enzymes. Is greatly facilitated, as demonstrated above. 
Use of spectrophotometry to monitor reaction rate eliminates 
the need for labeled tracers. Additionally, any hydrophobic 
material which can be derivatized to a carboxylic acid could 
be made water soluble by the formation of the activated 
esters of 1-hydroxy-2-n11ro-4-benzenesuIfonate. 
5.5. Immunogen Purification and Character 1zatI on 
Each step In the derI vat IzatI on process of methoprene 
was carefully monitored. All intermediates including a 
number of new compounds were synthesized and were 
characterized using thin layer chromatography, infrared 
spectroscopy, nuclear magnetic resonance, and elemental 
analysis. Appendix 1 contains all spectral data for the 
intermediates leading to methoprene>spacer (39). 
Initially, the juvenile hormone analog, farnesol (31), 
was also derivatlzed to form farnesoI>spacer (38). Although 
an Immunogen was not prepared from farnesol, reaction 
conditions leading to farnesoI>spacer (38) were successfully 
applied to the derI vat IzatI on of methoprene with similar 
good results. Since the specific reactions employed 
produced the desired products for two Juvenile hormone 
analogs, it is likely that these same reactions can be 
applied to other Juvenile hormone homologs or analogs if 
these materials can be derivatlzed to their carboxylic acid 
form. 
The methoprene Immunogen (hapten-carrier protein 
conjugate) was purified from low molecular weight by¬ 
products of the protein coupling reactions with exhaustive 
dialysis. Dialyzing the protein products against phosphate 
buffered saline (pH 7.4), followed by dialysis with 
distilled water, removed all unreacted starting materials 
and by-products very efficiently. Dialysis with distilled 
water was continued until no radioactivity was detected in 
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the dialysis wash. Sephadex (G25-40) column chromatography 
was also used to purify the protein products from the 
reaction with the 1-hydroxy-2-nItro-4-benzenesuIfonate 
activated ester (44). The protein product, however,st I I I 
required dialysis to remove trace amounts of unbound 
radiolabeled starting material and the yellow dianion by¬ 
product . 
i 
Character IzatI on of the Immunogen after dialysis and 
I yophI I IzatI on was done by direct liquid scintillation 
counting. This quantitative method of measuring the number 
of moles of methoprene bound per mole of protein carrier 
provided the most efficient and accurate determination. 
Other quantitative methods Include the monitoring of a 
change In absorbance of the hapten-protein carrier in a 
spectral region where the protein itself does not absorb 
(Hammock and Mumma, 1980), or monitoring of the proteins' 
reactive groups, such as free amine groups, before and after 
conjugation (Habeeb, 1966). Neither of these methods was 
employed due to the possibility that denaturation of the 
protein may affect the functionalities available for 
binding. These methods are also less direct, and perhaps 
less accurate than the use of a radiolabeled tracer. 
The methoprene Immunogen was subjected to a competitive 
binding assay to determine If the radiolabeled haptens were 
covalently or noncovaIentIy bound to the protein carrier 
(Figure 18). If the label was in the form of noncovaIent I y 
bound methoprene>spacer, It would have been displaced by 
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unlabeled methoprene>spacer which was present In an excess 
of one thousand times. The recovered Immunogen would not 
retain any of Its radioactivity after dialysis. This was 
not the case. The methoprene Immunogen lost none of Its 
radioactivity after competition with unlabeled 
methoprene>spacer, Indicating the hapten was covalently 
bound to the protein carrier, and the protein coupling 
reactions used to prepare the methoprene immunogen were a 
success. 
5.6. The Choice of Isotope for the Methoprene 
Immunogen Tracer 
Prior to receiving a gift of 5-14C-methoprene, the use 
of tritium was investigated as the Isotope for the 
methoprene immunogen tracer. Lithium dI IsopropyI am Ide was 
used to remove a proton in the '-position (2-C) of the 
carboxylic acid, methoprene>spacer (39), forming the lithium 
salt (Lochmann and Lim, 1973). Tritium, In the form of 
tritlated water, was added to a solution of the lithium 
salt, thus allowing for the exchange of lithium with tritium 
in the 2-C position. The tritlated product was stable under 
workup conditions and column chromatography, and contained 
1.3 x 106 counts min”1 mg”1. When 3H-methoprene>spacer was 
used to prepare the methoprene immunogen via a water soluble 
carbodilmlde coupling, the tritium label was lost under the 
acidic conditions necessary for the reaction. The resulting 
Protein product contained a trace amount of radioactivity, 
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and at the time, It was unclear as to the cause of the low 
Incorporation of the label. Two explanations were 
presented: a) the carbodilmide coupling method failed due to 
a lack of solubility of the reactants; and b) the tritium 
label exchanged freely with protons, and was removed from 
the protein product by dialysis. Both explanations were 
shown to be correct. 
The use of 14C-methoprene In the synthesis of 
methoprene>spacer showed that the carbodilmide coupling 
reaction was not successful If the reactants were not 
soluble. Subjecting 3H-methoprene>spacer to both acidic and 
basic conditions showed that the tritium label readily 
exchanged with protons under such conditions. This method 
of labeling a carboxylic acid with tritium did not 
incorporate the label to prevent It from being easily 
removed. The most stable form of a radiolabeled material Is 
one that has the Isotope directly Incorporated Into the 
structure of the compound. Thus, when 5-14C-methoprene 
became available. It was used in all subsequent methoprene 
derI vat Ization or protein conjugation reactions. 
5.7. Is the Methoprene Immunogen Immunogenic? 
The Immunization schedule for BALB/c mice Injected a 
minimal amount of Immunogen per booster shot per mouse 
(Figure 19). The production of antibodies in BALB/c mice 
a9aInst the methoprene immunogen was evident by the use of 
the indirct ELISA method (Figure 20). This preliminary 
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screening of the serum obtained from tall bleedings of the 
eight Immunized mice showed that the mice had, indeed 
mounted an immune response against the methoprene Immunogen 
(Table 5). This information was necessary to determine If 
the mice needed more booster shots of the immunogen, or If 
they were ready to receive sarcoma cells for the production 
of ascities fluid. Since the assay showed a strong response 
to the Immunogen from all eight mice (Table 5), It was 
decided that the mice were ready to receive the cancer 
cel Is. 
The information provided from this screening showed 
that the methoprene Immunogen could elicit an Immune 
response In mice. The degree of the response Is beyond the 
scope of this study, but will be Investigated In the future. 
5.8. Immunoassay Development 
Once antibodies have been raised In quantity and their 
specificity for methoprene has been established, a number of 
Immunoassays may be developed. The most widely used 
immunoassays Include radioimmunoassay (RIA), ELISA, or 
enzyme Immunoassay (EIA). The form that the Immunoassay for 
methoprene will take Is dependent on a number of factors. 
§_.8.i. Radioimmunoassay for Methoprene 
The radioimmunoassay is one of the most commonly used 
Immunological assays. A radioimmunoassay for methoprene 
could be developed with a specific antibody against 
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methoprene and a radiolabeled methoprene derivative with 
high specific activity. The radiolabeled tracers used in 
the Juvenile hormone radioimmunoassays have used 12^| jn the 
form of chloramine T (Baehr et al., 1976, Figure 7), or of 
an iodlnated tyrosine derivative (Strambi et al., 1981, 
Figure 8). 
Recently, methoprene derivatives with very high 
specific activity have been reported (Prestwich, 1987). 
3H-Methoprene was synthesized with a specific activity 
greater than 70 CI/mmoI. It may be possible to develop a 
highly sensitive methoprene radioimmunoassay with this 
derivative. The use of trItIum-IabeIed methoprene would 
insure that the radioimmunoassay would be detecting only 
methoprene. Such an Immunoassay would be useful in 
searching for endogenous methoprene, a phenomenon which may 
exist since high affinity binding sites have been found for 
methoprene In the nuclei of Manduca sexta epidermal cel Is 
(Prestwich, 1987). 
5.8.2. The Enzyme-Linked immunosorbent Assay 
The ELISA assay Is a widely used, simple, rapid and 
versatile method of measuring either antibody affinity or 
antigen concentration. The assay Is a discontinuous solid- 
phase system which usually Involves two cycles of three 
washings and a second antibody step (Steward and Lew, 1985). 
The antibody or antigen is conjugated to an enzyme capable 
of converting a chromagenlc substrate Into a colored 
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product. The sensitivity of the assay is very high since 
the enzyme is capable of converting 500,000 substrate 
molecules to product molecules per minute (DeToma and 
MacDonald, 1987). A spectrophotometer Is used to measure 
the concentration of enzyme present as a result of a 
competition reaction. The enzyme label replaces the 
radiolabel, making the assay more convenient, safer, and 
less costly for routine use. 
An enzyme-1 Inked Immunosorbant assay has not been 
reported for methoprene or any of the Juvenile hormones. 
The Indirect enzyme immunoassay method (Figure 20) was used 
to determine if antibodies had been produced against the 
methoprene immunogen. This type of immunoassay assay may 
also be modified to measure antigen concentration. 
A more direct method of measuring methoprene 
concentration would be to conjugate methoprene to an enzyme. 
This enzyme immunoassay (El A) first coats the methoprene 
immunogen-specific antibody to the solid support. A known 
amount of enzyme-conjugated methoprene is added to the wells 
along with an unknown amount of solution containing 
methoprene. The free methoprene would compete with enzyme- 
conjugated methoprene for binding sites on the absored 
antibody. Unbound methoprene and enzyme-conjugated 
methoprene would be washed away, and chromogenlc substrate 
would be added. The absorbance produced Is inversely 
Proportional to the amount of free antigen. Recently enzyme 
immunoassays have been developed for Juvenile hormone III 
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and Juvenile hormone III diol (Baehr et al., 1987), and are 
supposedly equivalent to or better than the 
radioimmunoassays using lodinated tracers. 
Both enzyme-1 1nked immunoassays have advantages and 
disadvantages. The ELISA method presents the antigen to the 
antibody on a solid surface. This may be problematic, 
partcularly for a small molecule like methoprene, which, 
when coated to a surface, may not present Itself to the 
antibody In a way that the antibody can recognize. The 
results obtained from the El A method are dependent on a lack 
of color. This also becomes a problem if one is assaying a 
colored sample. The presence of additional color would 
certainly decrease the sensitivity of this assay. 
Despite these problems, enzyme-1 Inked Immunoassays have 
many advantages over RIA. No radiolabeled tracer Is 
required, reducing risk and the use of protective facilities 
and equipment. The equipment needed for these assays is 
generally inexpensive and lends Itself well to automation. 
Enzyme-1 Inked Immunoassays, with a few modifications can be 
adapted to kit form, a I lowing for methoprene assay in the 
field. Samples may also be analyzed without expensive and 
time consuming purification procedures. 
5.9. Cone I us Ions 
The use of Immunological assays for the analysis of 
Pesticides has lagged far behind their use in clinical 
chemistry and endocrinology (Hammock and Mumma, 1980). It 
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is not likely that Immunological assays will replace current 
analytical methods of pesticide analysis. However, they may 
aid in the initial detection of pesticides, giving valuable 
Information as to the need to do more testing or to reapply 
the material for the optimal control. 
The Immunochemical techniques presented here will be 
used to develop immunological assays for methoprene. 
Methoprene was used as a model compound to present the 
general principles of how a non-Immunogen Ic material can be 
made Immunogenic. The procedures developed have allowed, 
for the first time, the production of a methoprene immunogen 
which was found to be Immunogenic In BALB/c mice. 
The derI vat IzatI on of methoprene, prior to conjugation 
to a protein, incorporated a four carbon spacer group via an 
ester function. The spacer group serves to mimic the ester 
function of methoprene, and acts as a flexible bridge 
between methoprene and the protein surface. Although there 
may be differences between native methoprene and the 
methoprene derivative conjugated to the protein, It Is hoped 
that the Immune system of the immunized animals will be 
encouraged to raise antibodies which specifically recognize 
methoprene. 
The use of activated esters Is a common method of 
conjugating small molecules to proteins. Two activated 
esters were used to conjugate methoprene to human serum 
albumin. The use of the N-hyroxysuccInImIde ester of 
methoprene modified procedures used for the preparation of 
immunogens for the Juvenile hormones. The modified method 
produced an immunogen with a high density of methoprene on 
the protein. This immunogen was subsequently used to 
immunIze mice. 
o 
The 1-hydroxy-2-nitro-4-benzenesuIfonate ester of 
methoprene was also synthesized and It enabled the complete 
solubilization of methoprene in aqueous solutions. This 
activated ester was coupled to human serum albumin in a 
fraction of the time needed for the N-hydroxysuccInImIde 
activated ester. Additionally, the reaction was carried out 
in a neutral buffer solution, as opposed to an 
aqueous/organic mixture of high pH. The density of 
methoprene on the resulting Immunogen was not as high (31 
molecules vs. 53 molecules of methoprene per molecule 
protein), but was higher than other reported Immunogens for 
Juvenile hormone. 
The complete synthetic process for the production of 
the methoprene Immunogen Is summarized in figure 22. These 
steps lead to the formation of an Immunogen with a four 
carbon spacer group. The four carbon spacer group was 
prepared from a lactone, forming a dlprotected intermediate 
which prevented the product from recyclizing to the lactone. 
The removal of the 2-(trImethIysI IyI)ethyl protecting 
residue used a reagent specific for that residue, insuring 
that no other functionalities would be attacked. The 
general method outlined (Figure 22) may be repeated with 
other carboxylic acids. The discovery that methoprene was 
133 
made water soluble when coupled to 1-hydroxy-2-nItro-4- 
benzenesuIfonIc acid may be applied to other organic 
materials to make them water soluble. 
The antibodies raised will be used to develop 
Imuunoassays for the detection of methoprene. Such assays. 
If properly developed, should detect methoprene in the 
nanogram to picogram range in biological and environmental 
samples. The assay should also produce results which can be 
validated with physIcaI-chemIcaI and analytical methods. 
5.10. Summary of Results 
1. Methoprene may be made immunogenic in mice by 
coupling it to a protein. 
2. The Incorporat I on of a four carbon spacer group 
retained the methoxy and ester functions that are 
characteristic of the methoprene molecule. 
3. Human serum albumin, the protein carrier of choice, 
allows for the conjugation of at least 53 methoprene 
molecules per molecule of albumin, and remains soluble at 
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Figure 22. Summary of synthetic steps required to produce 
the methoprene immunogen (45). 
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this density of hapten. 
4. The two activated ester methods of protein 
conjugation load many hapten molecules onto the protein 
under organic/aqueous or aqueous reaction solutions. 
6. The protecting groups used to protect the four 
carbon spacer group were removed with specific reagents 
under mild conditions. 
6. The use of a stable radioisotope such as allows 
for direct determination of the number of hapten molecules 
conjugated per molecule protein. 
7. The methods developed for the preparation of an 
immunogen may be app1 led to other non-ImmunogenIc carboxyl ic 
acids. 
8. Other water Insoluble carboxylic acids may be made 
water soluble by coupling to 1-hydroxy-2-nItro-4- 
benzenesu1fon Ic acid. 
9. The enyzme-1 Inked Immunosorbent assay was 
successfully used to detect antibodies In mouse serum which 
were specific for the methoprene Immunogen. 
Appendices 
Appendix A. 
Nuclear Magnetic Resonance 
and Infrared Spectra 
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Figure A-1. 1H NMR (CDCI3, 200 MHz) of 4- 
benzyIoxybutanoic acid (28). 
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Figure A-2 . IR (neat) of 4-benzyIoxybutanoic acid (28). 
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Figure A-3. NMR (CDC13, 60 MHz) of 2- 
(trimethyIsiIyI)ethyI 4-benzyIoxybutanoate (30). 
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Figure A-4. IR (neat) of 2-(trimethyIsiIyI)ethyI 4- 
benzyIoxybutanoate (30). 
?O
OJ
cm
*>
 
Figure A-5. 1H NMR (CDC13, 60 MHz) of 2- 
(trimethyIsiIyI)ethyI 4-hydroxybutanoate (31). 
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Figure A-6. IR (neat) of 2-(trImethyIsI IyI)ethyI 4- 
hydroxybutanoate (31). 
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Figure A-7. 1H NMR (CDCI3, 60 MHz) of 3,7,11-trimethyI 
2,6,10-dodecat rIenaI (33). 
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Figure A-8 . IR (neat) of 3,7,11-trimethyl-2,6,10- 
dodecatrIenaI (33). 

Figure A-9. 1H NMR (CDCI 3, 
2,6,1O-dodecat rienoic acid 
60 MHz) 
(34) . 
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IR (neat) of 3,7,11-trImethyI-2,6,10- 
c acid (34). 
F i gure A-10. 
dodecatrienoi 

Figure A-11. NMR (CDCI3, 
(trImethyIsI IyI)ethyI 4-(3, 
dodecatrienoyIoxy)butanoate 
60 MHz) of 2- 
,11-trimethy1-2,6,10- 
(36) . 
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Figure A-12. IR (neat) of 2-(trImethyIsI IyI)ethyI 4- 
(3,7,11—trlmethy1-2,6,10-dodecatrIenoyIoxy)butanoate 
(36) . 
?0
O
|cm
' 
Figure A-13. 1H NMR (CDC13, 60 MHz) of 4-(3,7,11- 
tr imethyI-2,6,10-dodecatrIenoyIoxy)butanoIc acid (38) 
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Figure A-14. IR (neat) of 4-(3,7,11-trImethyI-2f6,10- 
dodecatrIenoyIoxy)butanoIc acid (38). 
Figure A-15. 1H NMR (CDCI3, 60 MHz) of (2E, 4E)-11- 
methoxy-3,7,11-trimethyI-2,4-dodecadienoic acid (36). 
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Figure A-16. IR (neat) of (2E, 4E)-11-methoxy-3,7,11 
trimethyI-2,4-dodecadienoic acid (35). 
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Figure A-17. 1H NMR (CDC13, 60 MHz) of 2- 
(trimethyI si IyI)ethyI 4-(2E, 4E)-11-methoxy-3,7,11 
trimethyI-2,4-dodecadienoyIoxy)butanoate (37) . 
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Figure A-18. IR (neat) of 2-(trimethyIsiIyI)ethyI 4-(2E, 
4E)-11-methoxy-3,7,1 1-trimethy1-2,4- 
dodecadienoyIoxy)butanoate (37). 
§ 
r* 
§ 
<n 
8 
<0 
<n 
1
6
0
0
 
1
6
0
0
 
1
4
0
0
 
1
2
0
0
 
1
0
0
0
 
8
0
0
 
6
0
0
 
4
0
0
 
20
01
cf
n*
,
| 
175 
Figure A-19. 1H NMR (CDCI3, 60 MHz) of 4-(2E, 
methoxy-3,7,11-trI methy I-2,4-dodecadIenoyIoxy) 
acid (39). 
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Figure A- 
t rimethyI 
20. IR (neat) of 4-(2E 
-2,4-dodecadienoyIoxy) 
4E)-11-methoxy-3,7,11- 
butanoic acid (39). 
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Figure A-21. 1H NMR (CDC13, 60 MHz) of N- 
hydroxysucc I n i m i dy I 4— (2 4E^ -1 1 -methoxy-3,7,1 1 
trImethyI-2,4-dodecadIenoyIoxy) butanoate (41). 
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Figure A-22. IR (neat) of N-hydroxysuccInimidyI 4-(2E, 
4E)-11-methoxy-3,7,11-trImethyI-2,4-dodecadIenoyIoxy) 
butanoate (41). 
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Figure A-23. 1H NMR (D20, 200 MHz) of sodium 1-hydroxy-2- 
nItro-4—benzenesuIfonate (42). 

Figure A-24. IR (KBr) of sodium 1-hydroxy-2-nitro~4 
benzenesuIfonate (42). 

Appendix B. 
Calculation of the Number of Molecules 
Methoprene>Spacer Conjugated per Molecule of 
Using ^C-Methoprene as a Tracer 
of 
ProteIn 
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354.4 g/mol = Molecular weight methoprene>spacer 
69,000 g/mol = Molecular weight human serum albumin 
x = counts min-1 / mg protein conjugate 
y = counts min-1 / mg methoprene>spacer 
x * 100 * % methoprene>spacer on 1 mg 
y of protein conjugate 
— " ug methoprene>spacer on 1 mg protein conjugate 
_ x * ug protein conjugate 
1 - y 
Ratio of methoprene>spacer : protein 
x 
* _y 
X 
1 - y 
* ug methoprene>spacer 
ug protein conjugate 
* umol methoprene>spacer 
umoI protein conjugate 
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Sample Calculation for Trial 1, preparation of the 
methoprene immunogen via the 1-hydroxy-2-nItro-4- 
benzenesuIfonate (HNSA) activated ester: 
x * 2020 counts min“^ per mg protein conjugate 
y = 14,744 counts min-1 per mg methoprene>spacer 
x ' TOO = 13.7 %, or 137 ug methoprene>spacer on 1 
y mg protein conjugate 
Ratio of methoprene>spacer : protein conjugate 
= 137 ug_ 
1 mg - 137 ug 
■ 137 ug methoprene>spacer 
863 ug porteln conjugate 
■ 0.3864 umoI methoprene>spacer 
0.0125 umoI protein conjugate 
“ 31 molecules methoprene>spacer 
1 molecule protein conjugate 
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Appendix C. 
Calculation of the Number of Molecules of 
Methoprene>Spacer Conjugated per Molecule of Protein 
Using Spectrophotometry 
See Figures 15 and 17, pages 76 and 84 
equations. for chemical 
1. Calculation of the percentage HNSA-ester (44). 
A406NaOH = Absorbance of the above 
hydolysis with 5N NaOH. 
the total amount of free 
sample after complete 
This reading records 
dI an 1 on. 
% HNSA-ester - A4nRNaOH - A^e x 100 
A4Q6NaOH 
Eq. 1 
From Table 2, 
(44). page 77, 140 ug sample of crude HNSA-ester 
% HNSA-ester - 0.714 - o.son x 100 
0.714 
- 29.97 % 
2. Calculation of the number of 
?HSA)>Prene>SPaCer Per mo,ecul 
molecules of 
e of human serum a I bum In 
354.4 g/mol 
577.7 g/moI 
218.2 g/moI 
69,000 g/mol 
Sir1"- We'9ht (MW) of methoprene>spacer 
Molecular weight of methoprene>spacer-i 
(HNSA-e^;?!4 (4^"benzenesu 1 fonate ester 
benzenesu 17 onate tro-4- 
‘ Mo I ecu'ar weight of humah serum albumin 
For 140 ug of crude methoprene>spacer-HNSA 
a406 ■ 0.500 
(HNSA-ester), 
A406NaOH * 0.714 
To find the ratio, R, of 
140 ug of crude ester: HNSA-ester to free dianion I n 
Assumptions: 1 . Crude methoprene 
m moles dI an Ion >spacer-HNSA contains + n moles HNSA-ester. 
2* a4Q6 ' moles free dI an I on. 
3- A406NaOH ' moles total dI an I on 
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_a4QR = m = R Eq. 2 
A406^a^^* n + m 
= 0.500 = 0.700 
0.714 
Solving Eq. 2 for m, 
m = n ( R ) 
1 - R 
* n R * n 0.700 = 2.33 n 
1 - R 1 - 0.700 
Solving Eq. 2 for n, 
n * m (1 - R) 
R 
m 1 - R * m 1 - 0.700 = 0.429 m 
R 0.700 
To find n, mol ester In crude HNSA-ester.- 
welghtcrude ester * (MWd,an|on • m) + (MWester • n) 
Substituting for m and solving for n. 
n 
——we I ghtrri|de 
M^dlanlon R 
1 - R 
+ MVVes^er 
- _ 140 x 1Q~6 g 
g/mo I (2.3) + 577.7 g/mol 
* 0.129 x 10 ® mol HNSA-ester 
To find m, mol dIan Ion In crude HNSA-ester.- 
Substituting for n, and solving for m. 
m 
MW 
—We19ht^rnHo 
dI an I on + ^^ester R 
_140 x 10~6 g_ 
218.2 g/mol + 577.7 g/mol(0.429) 
Eq. 3 
0.290 x 10 6 mol dlanion 
It can further 
the HNSA—ester 
be assumed that from the 
and human serum albumin reaction between (Figure 17), 
moles of dlanion liberated 
moles ester reacted 
At t - 0, At 
therefore: Aq; mo,ester rxd * 0, so t *rxn end* 
and 
At 'mol 
* mo I 
Aq ' mol 
Therefore 
Aend 
mo,ester rxd 
dI an I on start 
dlanion start 
dI anlon start 
>> A0 
>> mo|dlanlon start 
+ mo1dI an I on lIberated 
+ molester rxd 
m°'^lnn + mo, 
mo1dI an I on start 
1 + mol 
mo I 
rVr1 
dlanion start 
mo I 
ester rxd = mo1dI an I on start(Af — 1) 
A0 
Eg. 4 
To determine the amount of dlanion at tho 4. 
reaction, amon at the start of each 
140 x 10 9 * 0.290 umol dlanion, 65.5 x 10“6 a 
and 0.129 umol ester, 74.5 x 10“6 g 
the 15 min reaction in ro m/i _ * . . 
used: ’ 0.52 mg of the crude ester was 
10.52 mg(0.290 umoI *, , , 
0.140 mg dlanion start) * 21.8 umol 
From Table 5, 
dI an I on star 
umo1 ester rxd - 21.8 umoldlan|on stapt (o,837 _ 1} 
0.750 
2.53 umoIester rxd 
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To determine the number of molecules of methoprene>spacer 
per molecule protein (from Table 5), 
* UmO I p«>tpr rvd 
umol protein 
- 2.53 UmOIQgfor rvH 
0.072 umoIprote,n 
* 34 molecules methoprene>spacer 
1 molecule protein 
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